Syrope personal page - To The Moon

Syrope

Syrope

No personal profile

116Follow

33Followers

0Topic

0Badge

2021-06-04

Like and comment pls

Sorry, the original content has been removed

2021-06-08

Like and comment please, thank u. Will replyur post

Sorry, the original content has been removed

2021-06-04

Like and comment pls

Sorry, the original content has been removed

2021-05-16

Comment and like please, thank you

Sorry, the original content has been removed

2021-05-07

Can someone respond to my comment?

Sorry, the original content has been removed

2021-05-29

Thankfully not another Ever Green! Like and comment pls, thanks

Sorry, the original content has been removed

2021-05-18

This means Tesla may continue to drop in prices.. oh no! Please like and comment, thanks

Sorry, the original content has been removed

2021-08-22

Like pls

Contrarian Investors Should Love Emerging Markets

2021-05-25

Like and comment please, ty

Sorry, the original content has been removed

2021-05-23

Comment and like please

Sorry, the original content has been removed

2021-06-30

Like please, thank u

Sorry, the original content has been removed

2021-09-13

Like pls

Hot chinese concept stocks dipped in morning trading

2021-06-18

Hope Ali returns to its high! Like and comment please

Sorry, the original content has been removed

2021-06-06

Like and comment please, thank you

Sorry, the original content has been removed

2021-05-24

Like and comment pls

Sorry, the original content has been removed

2021-05-07

Undervalued but still px too high for me, haha. Like and comment please, ty

Sorry, the original content has been removed

2021-08-20

Like please?

Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?

2021-08-11

Why wld they return the money... hmm pls like

Sorry, the original content has been removed

2021-07-28

Like please? Thanks

Sorry, the original content has been removed

2021-06-24

Tesla keep rising pls

Sorry, the original content has been removed

Go to Tiger App to see more news

Invest in Global Markets with Tiger Brokers!

Open App

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582110607927501","uuid":"3582110607927501","gmtCreate":1619022055314,"gmtModify":1629250969311,"name":"Syrope","pinyin":"syrope","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":33,"headSize":116,"tweetSize":149,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":863489934,"gmtCreate":1632411921828,"gmtModify":1676530777390,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/863489934","repostId":"1159478468","repostType":4,"repost":{"id":"1159478468","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632411695,"share":"https://ttm.financial/m/news/1159478468?lang=&edition=full_marsco","pubTime":"2021-09-23 23:41","market":"other","language":"en","title":"EngageSmart opens for trading at $37, up about 43.6% from IPO price","url":"https://stock-news.laohu8.com/highlight/detail?id=1159478468","media":"Tiger Newspress","summary":"(Sept 23) EngageSmart Inc. opens for trading at $37, up about 43.6% from IPO price.\n\nCompany\nBraintr","content":"<p>(Sept 23)&nbsp;<a href=\"https://laohu8.com/S/ESMT\">EngageSmart Inc.</a> opens for trading at $37, up about 43.6% from IPO price.</p>\n<p><img src=\"https://static.tigerbbs.com/835bc9b4ff09e761852f27f75743b887\" tg-width=\"898\" tg-height=\"550\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Company</b></p>\n<p>Braintree, Massachusetts-based EngageSmart was founded to develop a platform that improves customer engagement tailored for certain industry verticals.</p>\n<p>Management is headed by founder and CEO Robert P. Bennett, who has been with the firm since inception and was previously president of Sage Payment Solutions.</p>\n<p>The company's primary offerings include:</p>\n<ul>\n <li>SimplePractice - Wellness</li>\n <li>InvoiceCloud - Government, Utilities and Financial Services</li>\n <li>HealthPay24 - Healthcare</li>\n <li>DonorDrive - Non-profit and Corporate Fundraising</li>\n</ul>\n<p>EngageSmart has received at least $451 million in equity investment from investors including General Atlantic and Summit Partners.</p>\n<p><b>Customer Acquisition</b></p>\n<p>The firm pursues both large enterprise customers and SMB customers via its direct sales force and online service.</p>\n<p>As of June 30, 2021, the firm had served over 68,000 clients in the SMB market and more than 3,000 customers in its Enterprise Solutions segment.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>32.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>33.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>43.1%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Selling and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling and Marketing spend, dropped slightly to 1.1x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>1.1</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>1.3</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.</p>\n<p>ESMT's most recent calculation was 64% as of June 30, 2021, so the firm is performing well in this regard, per the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Rule of 40</b></p></td>\n   <td><p><b>Calculation</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Recent Rev. Growth %</p></td>\n   <td><p>59%</p></td>\n  </tr>\n  <tr>\n   <td><p>EBITDA %</p></td>\n   <td><p>5%</p></td>\n  </tr>\n  <tr>\n   <td><p>Total</p></td>\n   <td><p>64%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The firm's dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.</p>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2021 marketresearch reportby Mordor Intelligence, the global market for customer engagement solutions was an estimated $15.5 billion in 2020 and is forecast to reach $30.9 billion by 2026.</p>\n<p>This represents a forecast CAGR of 12.65% from 2021 to 2026.</p>\n<p>The main drivers for this expected growth are a growth in technology solutions to improve the customer journey via any device they use to connect with businesses.</p>\n<p>Also, a desire to reduce customer churn rate results in improved business financials and growing valuation.</p>\n<p>Below is a chart showing the variation in customer churn rates in different industries in the U.S. in 2018:</p>\n<p><img src=\"https://static.tigerbbs.com/f1066adb602d05e4e99630aacf61e1c5\" tg-width=\"1060\" tg-height=\"922\" referrerpolicy=\"no-referrer\">Major competitive or other industry participants include:</p>\n<ul>\n <li><p>IBM(NYSE:IBM)</p></li>\n <li><p>Microsoft(NASDAQ:MSFT)</p></li>\n <li><p>Nuance(NASDAQ:NUAN)</p></li>\n <li><p>Oracle(NYSE:ORCL)</p></li>\n <li><p>Salesforce(NYSE:CRM)</p></li>\n <li><p>Avaya(NYSE:AVYA)</p></li>\n <li><p>Calabrio</p></li>\n <li><p>Aspect Software</p></li>\n <li><p>Genesys</p></li>\n <li><p>Verint Systems(NASDAQ:VRNT)</p></li>\n <li><p>NICE Ltd.(NASDAQ:NICE)</p></li>\n <li><p>OpenText</p></li>\n <li><p>Pegasystems(NASDAQ:PEGA)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>EngageSmart's recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Growing topline revenue</p></li>\n <li><p>Increasing gross profit and high gross margin</p></li>\n <li><p>Growing operating profit and net income</p></li>\n <li><p>Increasing cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm's registration statement:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Total Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Total Revenue</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 99,171,000</p></td>\n   <td><p>58.6%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 146,557,000</p></td>\n   <td><p>77.8%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 82,432,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Profit (Loss)</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 73,673,000</p></td>\n   <td><p>61.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 108,964,000</p></td>\n   <td><p>89.2%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 57,591,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Margin</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>74.29%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>74.35%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>69.86%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Operating Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Operating Profit (Loss)</p></td>\n   <td><p>Operating Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 5,001,000</p></td>\n   <td><p>5.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 648,000</p></td>\n   <td><p>0.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (50,398,000)</p></td>\n   <td><p>-61.1%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Net Income (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Net Income (Loss)</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 274,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ (6,678,000)</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (53,598,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Cash Flow From Operations</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Cash Flow From Operations</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 12,044,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 19,645,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (1,427,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p>(Glossary Of Terms)</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As of June 30, 2021, EngageSmart had $31.8 million in cash and $151.8 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was $25.2 million.</p>\n<p><b>IPO Details</b></p>\n<p>ESMT intends to sell 13 million shares and selling shareholders will offer 1.55 million shares of common stock at a proposed midpoint price of $24.00 per share for gross proceeds of approximately $349 million, not including the sale of customary underwriter options.</p>\n<p>New potential investor Dragoneer Investment Group has indicated an interest to purchase 2.1 million shares of the offering or about $50.4 million at the proposed midpoint price.</p>\n<p>Assuming a successful IPO at the midpoint of the proposed price range, the company's enterprise value at IPO (ex- underwriter options) would approximate $3.7 billion.</p>\n<p>Excluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 9.04%. A figure under 10% is generally considered a 'low float' stock which can be subject to significant price volatility.</p>\n<p>Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:</p>\n<blockquote>\n We expect to use the net proceeds of this offering to repay in full the outstanding borrowings of approximately $114.2 million under our Credit Facilities. We currently intend to use the remaining net proceeds from this offering for general corporate purposes, including to fund our growth, acquire complementary businesses, products, services, or technologies, working capital, operating expenses, and capital expenditures.\n</blockquote>\n<blockquote>\n Source: SEC\n</blockquote>\n<p>Management's presentation of the company roadshow isavailable here.</p>\n<p>Regarding outstanding legal proceedings, management did not disclose any legal claims against the firm as of the regulatory filing date.</p>\n<p>Listed underwriters of the IPO are JPMorgan, Goldman Sachs, BofA Securities, and other investment banks.</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of the firm's relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Measure [TTM]</b></p></td>\n   <td><p><b>Amount</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Market Capitalization at IPO</p></td>\n   <td><p>$3,862,956,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Enterprise Value</p></td>\n   <td><p>$3,656,695,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>21.09</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>19.96</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>377.37</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$0.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Float To Outstanding Shares Ratio</p></td>\n   <td><p>9.04%</p></td>\n  </tr>\n  <tr>\n   <td><p>Proposed IPO Midpoint Price per Share</p></td>\n   <td><p>$24.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Net Free Cash Flow</p></td>\n   <td><p>$25,236,000</p></td>\n  </tr>\n  <tr>\n   <td><p>Free Cash Flow Yield Per Share</p></td>\n   <td><p>0.65%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>58.59%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As a reference, a potential public comparable would be NICE Ltd.; shown below is a comparison of their primary valuation metrics:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Metric</b></p></td>\n   <td><p><b>Nice Ltd.</b></p></td>\n   <td><p><b>EngageSmart</b></p></td>\n   <td><p><b>Variance</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>11.01</p></td>\n   <td><p>21.09</p></td>\n   <td><p>91.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>10.67</p></td>\n   <td><p>19.96</p></td>\n   <td><p>87.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>41.73</p></td>\n   <td><p>377.37</p></td>\n   <td><p>804.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$3.05</p></td>\n   <td><p>$0.00</p></td>\n   <td><p>-100.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>5.3%</p></td>\n   <td><p>58.59%</p></td>\n   <td><p>1003.34%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>(S-1/A andSeeking Alpha)</p>\n<p><b>Commentary</b></p>\n<p>ESMT is seeking public investment to pay down debt and for its general unspecified corporate growth plans.</p>\n<p>The firm's financials show strong topline revenue growth and gross profit growth, operating profit and a swing to slight net profit along with growing cash flow from operations.</p>\n<p>Free cash flow for the twelve months ended June 30, 2021, was a solid $25.2 million.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenue has increased and its Selling and Marketing efficiency rate dropped to 1.1x in the most recent six-month reporting period.</p>\n<p>The company's Rule of 40 performance was excellent and its dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The market opportunity for providing customer engagement software to businesses is large and expected to double in size by the end of 2026, so the company will be helped by strong industry growth dynamics.</p>\n<p>JPMorgan is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 20.4% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the company's outlook is the ability for larger firms to bundle some of their services into their existing offerings, resulting in downward pricing pressure and greater competition.</p>\n<p>As for valuation, compared to partial competitor NICE, ESMT is growing revenue much faster and so its much higher revenue multiples would appear to be justified.</p>\n<p>Also, the company is growing much faster than competitor Pegasystems, so seems to be taking market share from these and other companies in the customer engagement market.</p>\n<p>Given the firm's strong growth and operating metrics versus its competitors, while the IPO isn't cheap, it is worth consideration.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EngageSmart opens for trading at $37, up about 43.6% from IPO price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEngageSmart opens for trading at $37, up about 43.6% from IPO price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-23 23:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 23)&nbsp;<a href=\"https://laohu8.com/S/ESMT\">EngageSmart Inc.</a> opens for trading at $37, up about 43.6% from IPO price.</p>\n<p><img src=\"https://static.tigerbbs.com/835bc9b4ff09e761852f27f75743b887\" tg-width=\"898\" tg-height=\"550\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Company</b></p>\n<p>Braintree, Massachusetts-based EngageSmart was founded to develop a platform that improves customer engagement tailored for certain industry verticals.</p>\n<p>Management is headed by founder and CEO Robert P. Bennett, who has been with the firm since inception and was previously president of Sage Payment Solutions.</p>\n<p>The company's primary offerings include:</p>\n<ul>\n <li>SimplePractice - Wellness</li>\n <li>InvoiceCloud - Government, Utilities and Financial Services</li>\n <li>HealthPay24 - Healthcare</li>\n <li>DonorDrive - Non-profit and Corporate Fundraising</li>\n</ul>\n<p>EngageSmart has received at least $451 million in equity investment from investors including General Atlantic and Summit Partners.</p>\n<p><b>Customer Acquisition</b></p>\n<p>The firm pursues both large enterprise customers and SMB customers via its direct sales force and online service.</p>\n<p>As of June 30, 2021, the firm had served over 68,000 clients in the SMB market and more than 3,000 customers in its Enterprise Solutions segment.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>32.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>33.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>43.1%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Selling and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling and Marketing spend, dropped slightly to 1.1x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling and Marketing</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>1.1</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>1.3</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.</p>\n<p>ESMT's most recent calculation was 64% as of June 30, 2021, so the firm is performing well in this regard, per the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Rule of 40</b></p></td>\n   <td><p><b>Calculation</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Recent Rev. Growth %</p></td>\n   <td><p>59%</p></td>\n  </tr>\n  <tr>\n   <td><p>EBITDA %</p></td>\n   <td><p>5%</p></td>\n  </tr>\n  <tr>\n   <td><p>Total</p></td>\n   <td><p>64%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>The firm's dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.</p>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2021 marketresearch reportby Mordor Intelligence, the global market for customer engagement solutions was an estimated $15.5 billion in 2020 and is forecast to reach $30.9 billion by 2026.</p>\n<p>This represents a forecast CAGR of 12.65% from 2021 to 2026.</p>\n<p>The main drivers for this expected growth are a growth in technology solutions to improve the customer journey via any device they use to connect with businesses.</p>\n<p>Also, a desire to reduce customer churn rate results in improved business financials and growing valuation.</p>\n<p>Below is a chart showing the variation in customer churn rates in different industries in the U.S. in 2018:</p>\n<p><img src=\"https://static.tigerbbs.com/f1066adb602d05e4e99630aacf61e1c5\" tg-width=\"1060\" tg-height=\"922\" referrerpolicy=\"no-referrer\">Major competitive or other industry participants include:</p>\n<ul>\n <li><p>IBM(NYSE:IBM)</p></li>\n <li><p>Microsoft(NASDAQ:MSFT)</p></li>\n <li><p>Nuance(NASDAQ:NUAN)</p></li>\n <li><p>Oracle(NYSE:ORCL)</p></li>\n <li><p>Salesforce(NYSE:CRM)</p></li>\n <li><p>Avaya(NYSE:AVYA)</p></li>\n <li><p>Calabrio</p></li>\n <li><p>Aspect Software</p></li>\n <li><p>Genesys</p></li>\n <li><p>Verint Systems(NASDAQ:VRNT)</p></li>\n <li><p>NICE Ltd.(NASDAQ:NICE)</p></li>\n <li><p>OpenText</p></li>\n <li><p>Pegasystems(NASDAQ:PEGA)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>EngageSmart's recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Growing topline revenue</p></li>\n <li><p>Increasing gross profit and high gross margin</p></li>\n <li><p>Growing operating profit and net income</p></li>\n <li><p>Increasing cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm's registration statement:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Total Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Total Revenue</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 99,171,000</p></td>\n   <td><p>58.6%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 146,557,000</p></td>\n   <td><p>77.8%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 82,432,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Profit (Loss)</p></td>\n   <td><p>% Variance vs. Prior</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 73,673,000</p></td>\n   <td><p>61.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 108,964,000</p></td>\n   <td><p>89.2%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ 57,591,000</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Gross Margin</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Gross Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>74.29%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>74.35%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>69.86%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Operating Profit (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Operating Profit (Loss)</p></td>\n   <td><p>Operating Margin</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 5,001,000</p></td>\n   <td><p>5.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 648,000</p></td>\n   <td><p>0.4%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (50,398,000)</p></td>\n   <td><p>-61.1%</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Net Income (Loss)</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Net Income (Loss)</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 274,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ (6,678,000)</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (53,598,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p><b>Cash Flow From Operations</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Cash Flow From Operations</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>$ 12,044,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>$ 19,645,000</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>$ (1,427,000)</p></td>\n  </tr>\n  <tr></tr>\n  <tr>\n   <td><p>(Glossary Of Terms)</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As of June 30, 2021, EngageSmart had $31.8 million in cash and $151.8 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was $25.2 million.</p>\n<p><b>IPO Details</b></p>\n<p>ESMT intends to sell 13 million shares and selling shareholders will offer 1.55 million shares of common stock at a proposed midpoint price of $24.00 per share for gross proceeds of approximately $349 million, not including the sale of customary underwriter options.</p>\n<p>New potential investor Dragoneer Investment Group has indicated an interest to purchase 2.1 million shares of the offering or about $50.4 million at the proposed midpoint price.</p>\n<p>Assuming a successful IPO at the midpoint of the proposed price range, the company's enterprise value at IPO (ex- underwriter options) would approximate $3.7 billion.</p>\n<p>Excluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 9.04%. A figure under 10% is generally considered a 'low float' stock which can be subject to significant price volatility.</p>\n<p>Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:</p>\n<blockquote>\n We expect to use the net proceeds of this offering to repay in full the outstanding borrowings of approximately $114.2 million under our Credit Facilities. We currently intend to use the remaining net proceeds from this offering for general corporate purposes, including to fund our growth, acquire complementary businesses, products, services, or technologies, working capital, operating expenses, and capital expenditures.\n</blockquote>\n<blockquote>\n Source: SEC\n</blockquote>\n<p>Management's presentation of the company roadshow isavailable here.</p>\n<p>Regarding outstanding legal proceedings, management did not disclose any legal claims against the firm as of the regulatory filing date.</p>\n<p>Listed underwriters of the IPO are JPMorgan, Goldman Sachs, BofA Securities, and other investment banks.</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of the firm's relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Measure [TTM]</b></p></td>\n   <td><p><b>Amount</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Market Capitalization at IPO</p></td>\n   <td><p>$3,862,956,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Enterprise Value</p></td>\n   <td><p>$3,656,695,720</p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>21.09</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>19.96</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>377.37</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$0.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Float To Outstanding Shares Ratio</p></td>\n   <td><p>9.04%</p></td>\n  </tr>\n  <tr>\n   <td><p>Proposed IPO Midpoint Price per Share</p></td>\n   <td><p>$24.00</p></td>\n  </tr>\n  <tr>\n   <td><p>Net Free Cash Flow</p></td>\n   <td><p>$25,236,000</p></td>\n  </tr>\n  <tr>\n   <td><p>Free Cash Flow Yield Per Share</p></td>\n   <td><p>0.65%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>58.59%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>Source: SEC</p>\n<p>As a reference, a potential public comparable would be NICE Ltd.; shown below is a comparison of their primary valuation metrics:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Metric</b></p></td>\n   <td><p><b>Nice Ltd.</b></p></td>\n   <td><p><b>EngageSmart</b></p></td>\n   <td><p><b>Variance</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Price / Sales</p></td>\n   <td><p>11.01</p></td>\n   <td><p>21.09</p></td>\n   <td><p>91.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / Revenue</p></td>\n   <td><p>10.67</p></td>\n   <td><p>19.96</p></td>\n   <td><p>87.1%</p></td>\n  </tr>\n  <tr>\n   <td><p>EV / EBITDA</p></td>\n   <td><p>41.73</p></td>\n   <td><p>377.37</p></td>\n   <td><p>804.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>Earnings Per Share</p></td>\n   <td><p>$3.05</p></td>\n   <td><p>$0.00</p></td>\n   <td><p>-100.0%</p></td>\n  </tr>\n  <tr>\n   <td><p>Revenue Growth Rate</p></td>\n   <td><p>5.3%</p></td>\n   <td><p>58.59%</p></td>\n   <td><p>1003.34%</p></td>\n  </tr>\n  <tr></tr>\n </tbody>\n</table>\n<p>(S-1/A andSeeking Alpha)</p>\n<p><b>Commentary</b></p>\n<p>ESMT is seeking public investment to pay down debt and for its general unspecified corporate growth plans.</p>\n<p>The firm's financials show strong topline revenue growth and gross profit growth, operating profit and a swing to slight net profit along with growing cash flow from operations.</p>\n<p>Free cash flow for the twelve months ended June 30, 2021, was a solid $25.2 million.</p>\n<p>Selling and Marketing expenses as a percentage of total revenue have dropped as revenue has increased and its Selling and Marketing efficiency rate dropped to 1.1x in the most recent six-month reporting period.</p>\n<p>The company's Rule of 40 performance was excellent and its dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.</p>\n<p>The market opportunity for providing customer engagement software to businesses is large and expected to double in size by the end of 2026, so the company will be helped by strong industry growth dynamics.</p>\n<p>JPMorgan is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 20.4% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the company's outlook is the ability for larger firms to bundle some of their services into their existing offerings, resulting in downward pricing pressure and greater competition.</p>\n<p>As for valuation, compared to partial competitor NICE, ESMT is growing revenue much faster and so its much higher revenue multiples would appear to be justified.</p>\n<p>Also, the company is growing much faster than competitor Pegasystems, so seems to be taking market share from these and other companies in the customer engagement market.</p>\n<p>Given the firm's strong growth and operating metrics versus its competitors, while the IPO isn't cheap, it is worth consideration.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ESMT":"EngageSmart Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159478468","content_text":"(Sept 23) EngageSmart Inc. opens for trading at $37, up about 43.6% from IPO price.\n\nCompany\nBraintree, Massachusetts-based EngageSmart was founded to develop a platform that improves customer engagement tailored for certain industry verticals.\nManagement is headed by founder and CEO Robert P. Bennett, who has been with the firm since inception and was previously president of Sage Payment Solutions.\nThe company's primary offerings include:\n\nSimplePractice - Wellness\nInvoiceCloud - Government, Utilities and Financial Services\nHealthPay24 - Healthcare\nDonorDrive - Non-profit and Corporate Fundraising\n\nEngageSmart has received at least $451 million in equity investment from investors including General Atlantic and Summit Partners.\nCustomer Acquisition\nThe firm pursues both large enterprise customers and SMB customers via its direct sales force and online service.\nAs of June 30, 2021, the firm had served over 68,000 clients in the SMB market and more than 3,000 customers in its Enterprise Solutions segment.\nSelling and Marketing expenses as a percentage of total revenue have dropped as revenues have increased, as the figures below indicate:\n\n\n\n\nSelling and Marketing\nExpenses vs. Revenue\n\n\nPeriod\nPercentage\n\n\nSix Mos. Ended June 30, 2021\n32.4%\n\n\n2020\n33.1%\n\n\n2019\n43.1%\n\n\n\nSource: SEC\nThe Selling and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling and Marketing spend, dropped slightly to 1.1x in the most recent reporting period, as shown in the table below:\n\n\n\n\nSelling and Marketing\nEfficiency Rate\n\n\nPeriod\nMultiple\n\n\nSix Mos. Ended June 30, 2021\n1.1\n\n\n2020\n1.3\n\n\n\nSource: SEC\nThe Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.\nESMT's most recent calculation was 64% as of June 30, 2021, so the firm is performing well in this regard, per the table below:\n\n\n\n\nRule of 40\nCalculation\n\n\nRecent Rev. Growth %\n59%\n\n\nEBITDA %\n5%\n\n\nTotal\n64%\n\n\n\nSource: SEC\nThe firm's dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.\nThe dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.\nMarket & Competition\nAccording to a 2021 marketresearch reportby Mordor Intelligence, the global market for customer engagement solutions was an estimated $15.5 billion in 2020 and is forecast to reach $30.9 billion by 2026.\nThis represents a forecast CAGR of 12.65% from 2021 to 2026.\nThe main drivers for this expected growth are a growth in technology solutions to improve the customer journey via any device they use to connect with businesses.\nAlso, a desire to reduce customer churn rate results in improved business financials and growing valuation.\nBelow is a chart showing the variation in customer churn rates in different industries in the U.S. in 2018:\nMajor competitive or other industry participants include:\n\nIBM(NYSE:IBM)\nMicrosoft(NASDAQ:MSFT)\nNuance(NASDAQ:NUAN)\nOracle(NYSE:ORCL)\nSalesforce(NYSE:CRM)\nAvaya(NYSE:AVYA)\nCalabrio\nAspect Software\nGenesys\nVerint Systems(NASDAQ:VRNT)\nNICE Ltd.(NASDAQ:NICE)\nOpenText\nPegasystems(NASDAQ:PEGA)\nOthers\n\nFinancial Performance\nEngageSmart's recent financial results can be summarized as follows:\n\nGrowing topline revenue\nIncreasing gross profit and high gross margin\nGrowing operating profit and net income\nIncreasing cash flow from operations\n\nBelow are relevant financial results derived from the firm's registration statement:\n\n\n\n\nTotal Revenue\n\n\nPeriod\nTotal Revenue\n% Variance vs. Prior\n\n\nSix Mos. Ended June 30, 2021\n$ 99,171,000\n58.6%\n\n\n2020\n$ 146,557,000\n77.8%\n\n\n2019\n$ 82,432,000\n\n\n\nGross Profit (Loss)\n\n\nPeriod\nGross Profit (Loss)\n% Variance vs. Prior\n\n\nSix Mos. Ended June 30, 2021\n$ 73,673,000\n61.4%\n\n\n2020\n$ 108,964,000\n89.2%\n\n\n2019\n$ 57,591,000\n\n\n\nGross Margin\n\n\nPeriod\nGross Margin\n\n\nSix Mos. Ended June 30, 2021\n74.29%\n\n\n2020\n74.35%\n\n\n2019\n69.86%\n\n\n\nOperating Profit (Loss)\n\n\nPeriod\nOperating Profit (Loss)\nOperating Margin\n\n\nSix Mos. Ended June 30, 2021\n$ 5,001,000\n5.0%\n\n\n2020\n$ 648,000\n0.4%\n\n\n2019\n$ (50,398,000)\n-61.1%\n\n\n\nNet Income (Loss)\n\n\nPeriod\nNet Income (Loss)\n\n\nSix Mos. Ended June 30, 2021\n$ 274,000\n\n\n2020\n$ (6,678,000)\n\n\n2019\n$ (53,598,000)\n\n\n\nCash Flow From Operations\n\n\nPeriod\nCash Flow From Operations\n\n\nSix Mos. Ended June 30, 2021\n$ 12,044,000\n\n\n2020\n$ 19,645,000\n\n\n2019\n$ (1,427,000)\n\n\n\n(Glossary Of Terms)\n\n\n\nSource: SEC\nAs of June 30, 2021, EngageSmart had $31.8 million in cash and $151.8 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021, was $25.2 million.\nIPO Details\nESMT intends to sell 13 million shares and selling shareholders will offer 1.55 million shares of common stock at a proposed midpoint price of $24.00 per share for gross proceeds of approximately $349 million, not including the sale of customary underwriter options.\nNew potential investor Dragoneer Investment Group has indicated an interest to purchase 2.1 million shares of the offering or about $50.4 million at the proposed midpoint price.\nAssuming a successful IPO at the midpoint of the proposed price range, the company's enterprise value at IPO (ex- underwriter options) would approximate $3.7 billion.\nExcluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 9.04%. A figure under 10% is generally considered a 'low float' stock which can be subject to significant price volatility.\nPer the firm's most recent regulatory filing, it plans to use the net proceeds as follows:\n\n We expect to use the net proceeds of this offering to repay in full the outstanding borrowings of approximately $114.2 million under our Credit Facilities. We currently intend to use the remaining net proceeds from this offering for general corporate purposes, including to fund our growth, acquire complementary businesses, products, services, or technologies, working capital, operating expenses, and capital expenditures.\n\n\n Source: SEC\n\nManagement's presentation of the company roadshow isavailable here.\nRegarding outstanding legal proceedings, management did not disclose any legal claims against the firm as of the regulatory filing date.\nListed underwriters of the IPO are JPMorgan, Goldman Sachs, BofA Securities, and other investment banks.\nValuation Metrics\nBelow is a table of the firm's relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:\n\n\n\n\nMeasure [TTM]\nAmount\n\n\nMarket Capitalization at IPO\n$3,862,956,720\n\n\nEnterprise Value\n$3,656,695,720\n\n\nPrice / Sales\n21.09\n\n\nEV / Revenue\n19.96\n\n\nEV / EBITDA\n377.37\n\n\nEarnings Per Share\n$0.00\n\n\nFloat To Outstanding Shares Ratio\n9.04%\n\n\nProposed IPO Midpoint Price per Share\n$24.00\n\n\nNet Free Cash Flow\n$25,236,000\n\n\nFree Cash Flow Yield Per Share\n0.65%\n\n\nRevenue Growth Rate\n58.59%\n\n\n\n\nSource: SEC\nAs a reference, a potential public comparable would be NICE Ltd.; shown below is a comparison of their primary valuation metrics:\n\n\n\n\nMetric\nNice Ltd.\nEngageSmart\nVariance\n\n\nPrice / Sales\n11.01\n21.09\n91.5%\n\n\nEV / Revenue\n10.67\n19.96\n87.1%\n\n\nEV / EBITDA\n41.73\n377.37\n804.3%\n\n\nEarnings Per Share\n$3.05\n$0.00\n-100.0%\n\n\nRevenue Growth Rate\n5.3%\n58.59%\n1003.34%\n\n\n\n\n(S-1/A andSeeking Alpha)\nCommentary\nESMT is seeking public investment to pay down debt and for its general unspecified corporate growth plans.\nThe firm's financials show strong topline revenue growth and gross profit growth, operating profit and a swing to slight net profit along with growing cash flow from operations.\nFree cash flow for the twelve months ended June 30, 2021, was a solid $25.2 million.\nSelling and Marketing expenses as a percentage of total revenue have dropped as revenue has increased and its Selling and Marketing efficiency rate dropped to 1.1x in the most recent six-month reporting period.\nThe company's Rule of 40 performance was excellent and its dollar-based net revenue retention rate for the year ended December 31, 2020, was 124%, a strong result.\nThe market opportunity for providing customer engagement software to businesses is large and expected to double in size by the end of 2026, so the company will be helped by strong industry growth dynamics.\nJPMorgan is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 20.4% since their IPO. This is a mid-tier performance for all major underwriters during the period.\nThe primary risk to the company's outlook is the ability for larger firms to bundle some of their services into their existing offerings, resulting in downward pricing pressure and greater competition.\nAs for valuation, compared to partial competitor NICE, ESMT is growing revenue much faster and so its much higher revenue multiples would appear to be justified.\nAlso, the company is growing much faster than competitor Pegasystems, so seems to be taking market share from these and other companies in the customer engagement market.\nGiven the firm's strong growth and operating metrics versus its competitors, while the IPO isn't cheap, it is worth consideration.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1339,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577242908888293","authorId":"3577242908888293","name":"xvin23","avatar":"https://static.tigerbbs.com/284ea65037fdd70740d1782f2b4e7dc7","crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3577242908888293","idStr":"3577242908888293"},"content":"Pls lIke my comment","text":"Pls lIke my comment","html":"Pls lIke my comment"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887872627,"gmtCreate":1632022096569,"gmtModify":1676530688171,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Stay safe, everyone! Like pls","listText":"Stay safe, everyone! Like pls","text":"Stay safe, everyone! Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/887872627","repostId":"2168089015","repostType":4,"isVote":1,"tweetType":1,"viewCount":1458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884281280,"gmtCreate":1631893775640,"gmtModify":1676530664953,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like please?","listText":"Like please?","text":"Like please?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/884281280","repostId":"2168885573","repostType":4,"repost":{"id":"2168885573","kind":"highlight","pubTimestamp":1631892652,"share":"https://ttm.financial/m/news/2168885573?lang=&edition=full_marsco","pubTime":"2021-09-17 23:30","market":"us","language":"en","title":"This Dow Jones Stock Could Double Your Money","url":"https://stock-news.laohu8.com/highlight/detail?id=2168885573","media":"Motley Fool","summary":"The iconic blue-chip index has made some big changes in recent years to better reflect the modern marketplace.","content":"<p>The 30 names that make up the <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) are certainly well-respected blue chips. But potential doublers? That seems unlikely -- at least in the foreseeable future. After all, the Dow is a collection of the market's oldest, stodgiest, and slowest-moving companies meant for your grandmother's portfolio, right?</p>\n<p>If that's your perception of the Dow Jones Industrial Average, you might want to take another look. In recent years, the DJIA has been tweaked and modernized for the current tech-driven era. More than that, though, it includes a handful of companies that are anything but old school. One of these stocks even has the potential to double its value (again) in less than five years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/631cf3238264bad315f43eda4132590c\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>It's not yesteryear's Dow Jones Industrial Average</h2>\n<p>The Dow component that has this potential: <b><a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com</b> (NYSE:CRM).</p>\n<p>Yes, the provider of a cloud-based, customer relationship management platform is, in fact, a DJIA component. It was added to the index in August 2020 (in the midst of the pandemic) along with <b>Amgen</b> (NASDAQ:AMGN) and <b>Honeywell</b> (NASDAQ:HON), replacing more-traditional stocks like <b>ExxonMobil</b>, <b>Pfizer</b>, and <b>Raytheon Technologies</b>.</p>\n<p>That round of swapping was the latest in a bigger effort to bring the index further into the 21st century. Unsurprisingly, it has juiced the Dow's returns just a bit. It's up more than 90% for the past five years despite the early 2020 swoon linked to the onset of COVID-19, and higher by 200% for the past 10 years.</p>\n<p>Salesforce didn't contribute to most of that bullish effort, but don't be surprised if it's a key driver of similar gains in the Dow over the next five- and 10-year stretches.</p>\n<h2>Salesforce's bright future</h2>\n<p>If you're not familiar with it, Salesforce is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the original companies to commercialize cloud computing, before the term even began to be widely used. Its online customer database and customer-management platform were launched in 1999, and there was nothing else quite like it at the time.</p>\n<p>That's certainly changed in the meantime. Not only is the customer relationship management (CRM) space now relatively crowded with competitors, but after 22 years of availability, the whole CRM thing has seemingly run most of its course. What's left?</p>\n<p>As it turns out, for Salesforce, quite a lot.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/70402b628ff39aa410477caa22af642c\" tg-width=\"700\" tg-height=\"525\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>The best days for basic CRM offerings might be in the rearview mirror, but what lies ahead are all sorts of revenue-bearing integrations with Salesforce's existing platform. For instance, earlier this week <b>FedEx</b> announced a partnership with Salesforce that will offer e-commerce and supply chain tools to business clients with such a need. In July, Salesforce completed its acquisition of intra-enterprise communication platform Slack, and by August had integrated its CRM tools with Slack's user interface. Salesforce-owned Tableau, which helps organizations collect and analyze all sorts of data, unveiled changes to its service earlier this month that will make it more secure, yet also easier to use at a greater scale.</p>\n<p>And this is just a recent sampling of how the company continues to improve its suite of services. Others have yet to be imagined. They're coming, though, spurred by the emerging new norm in workplaces: working from home (or at least working there more often).</p>\n<h2>Capitalizing on the new norm</h2>\n<p>This wasn't exactly the plan a year ago. Most organizations that expected employees to regularly report to an office before the pandemic similarly expected them to return to the office once the pandemic had passed. Working from home has worked out better than most organizations could have hoped, however, and given that the coronavirus has yet to fully pass (and might never really do so), at least some companies are rethinking their office-attendance policies altogether.</p>\n<p>Take researcher Omdia's recent Future of Work survey as an example. It indicates that more than two-thirds of all U.S. employers believe overall productivity has improved since workers were allowed to do their jobs outside of a centralized office. The same survey suggests more than half of all employees will be doing at least some work from home for the indefinite future.</p>\n<p>In this vein, PwC reports that 72% of U.S. executives currently plan to increase their investment in virtual (online) collaboration tools. Technology market researcher IDC forecasts that spending on work-based software -- including cloud-based collaboration and analytics tools -- will grow more than 21% per year through 2024.</p>\n<p>It all plays right into Salesforce's hands, setting the stage for the stock to move from its current price near $257 to a value in excess of $500.</p>\n<h2>Bottom line</h2>\n<p>There's still something of a wait before we see that move fully pan out, to be clear.</p>\n<p>Salesforce is in the right place at the right time, and it's poised for more double-digit percentage growth for the next several years. But there are limits. This company's clients are other companies, for example, which tend to move slowly when making purchases and entering new service contracts no matter how great the need.</p>\n<p>Compared to any other Dow component, though, Salesforce is still easily the company that's best positioned for strong, reliable growth for the next several years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3348cbed1f7f70f45b84749230a42902\" tg-width=\"700\" tg-height=\"441\" width=\"100%\" height=\"auto\"><span>Data source: Thomson Reuters. Chart by author. Revenue data is in millions of dollars.</span></p>\n<p>It's also worth noting that last year's pandemic-prompted profit surge isn't expected to be repeated, but easily could be repeated now that corporations have had time to think about and better plan their IT budgets.</p>\n<p>In other words, CRM is absolutely worth the wait, although investors shouldn't have to wait too long before starting to make progress toward a doubling of the stock's price.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Dow Jones Stock Could Double Your Money</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Dow Jones Stock Could Double Your Money\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/17/dow-jones-stock-could-double-your-money-crm/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The 30 names that make up the Dow Jones Industrial Average (DJINDICES:^DJI) are certainly well-respected blue chips. But potential doublers? That seems unlikely -- at least in the foreseeable future. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/17/dow-jones-stock-could-double-your-money-crm/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRM":"赛富时"},"source_url":"https://www.fool.com/investing/2021/09/17/dow-jones-stock-could-double-your-money-crm/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168885573","content_text":"The 30 names that make up the Dow Jones Industrial Average (DJINDICES:^DJI) are certainly well-respected blue chips. But potential doublers? That seems unlikely -- at least in the foreseeable future. After all, the Dow is a collection of the market's oldest, stodgiest, and slowest-moving companies meant for your grandmother's portfolio, right?\nIf that's your perception of the Dow Jones Industrial Average, you might want to take another look. In recent years, the DJIA has been tweaked and modernized for the current tech-driven era. More than that, though, it includes a handful of companies that are anything but old school. One of these stocks even has the potential to double its value (again) in less than five years.\nImage source: Getty Images.\nIt's not yesteryear's Dow Jones Industrial Average\nThe Dow component that has this potential: Salesforce.com (NYSE:CRM).\nYes, the provider of a cloud-based, customer relationship management platform is, in fact, a DJIA component. It was added to the index in August 2020 (in the midst of the pandemic) along with Amgen (NASDAQ:AMGN) and Honeywell (NASDAQ:HON), replacing more-traditional stocks like ExxonMobil, Pfizer, and Raytheon Technologies.\nThat round of swapping was the latest in a bigger effort to bring the index further into the 21st century. Unsurprisingly, it has juiced the Dow's returns just a bit. It's up more than 90% for the past five years despite the early 2020 swoon linked to the onset of COVID-19, and higher by 200% for the past 10 years.\nSalesforce didn't contribute to most of that bullish effort, but don't be surprised if it's a key driver of similar gains in the Dow over the next five- and 10-year stretches.\nSalesforce's bright future\nIf you're not familiar with it, Salesforce is one of the original companies to commercialize cloud computing, before the term even began to be widely used. Its online customer database and customer-management platform were launched in 1999, and there was nothing else quite like it at the time.\nThat's certainly changed in the meantime. Not only is the customer relationship management (CRM) space now relatively crowded with competitors, but after 22 years of availability, the whole CRM thing has seemingly run most of its course. What's left?\nAs it turns out, for Salesforce, quite a lot.\nImage source: Getty Images.\nThe best days for basic CRM offerings might be in the rearview mirror, but what lies ahead are all sorts of revenue-bearing integrations with Salesforce's existing platform. For instance, earlier this week FedEx announced a partnership with Salesforce that will offer e-commerce and supply chain tools to business clients with such a need. In July, Salesforce completed its acquisition of intra-enterprise communication platform Slack, and by August had integrated its CRM tools with Slack's user interface. Salesforce-owned Tableau, which helps organizations collect and analyze all sorts of data, unveiled changes to its service earlier this month that will make it more secure, yet also easier to use at a greater scale.\nAnd this is just a recent sampling of how the company continues to improve its suite of services. Others have yet to be imagined. They're coming, though, spurred by the emerging new norm in workplaces: working from home (or at least working there more often).\nCapitalizing on the new norm\nThis wasn't exactly the plan a year ago. Most organizations that expected employees to regularly report to an office before the pandemic similarly expected them to return to the office once the pandemic had passed. Working from home has worked out better than most organizations could have hoped, however, and given that the coronavirus has yet to fully pass (and might never really do so), at least some companies are rethinking their office-attendance policies altogether.\nTake researcher Omdia's recent Future of Work survey as an example. It indicates that more than two-thirds of all U.S. employers believe overall productivity has improved since workers were allowed to do their jobs outside of a centralized office. The same survey suggests more than half of all employees will be doing at least some work from home for the indefinite future.\nIn this vein, PwC reports that 72% of U.S. executives currently plan to increase their investment in virtual (online) collaboration tools. Technology market researcher IDC forecasts that spending on work-based software -- including cloud-based collaboration and analytics tools -- will grow more than 21% per year through 2024.\nIt all plays right into Salesforce's hands, setting the stage for the stock to move from its current price near $257 to a value in excess of $500.\nBottom line\nThere's still something of a wait before we see that move fully pan out, to be clear.\nSalesforce is in the right place at the right time, and it's poised for more double-digit percentage growth for the next several years. But there are limits. This company's clients are other companies, for example, which tend to move slowly when making purchases and entering new service contracts no matter how great the need.\nCompared to any other Dow component, though, Salesforce is still easily the company that's best positioned for strong, reliable growth for the next several years.\nData source: Thomson Reuters. Chart by author. Revenue data is in millions of dollars.\nIt's also worth noting that last year's pandemic-prompted profit surge isn't expected to be repeated, but easily could be repeated now that corporations have had time to think about and better plan their IT budgets.\nIn other words, CRM is absolutely worth the wait, although investors shouldn't have to wait too long before starting to make progress toward a doubling of the stock's price.","news_type":1},"isVote":1,"tweetType":1,"viewCount":942,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882470798,"gmtCreate":1631717152814,"gmtModify":1676530617680,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/882470798","repostId":"1118481158","repostType":4,"repost":{"id":"1118481158","kind":"news","pubTimestamp":1631703727,"share":"https://ttm.financial/m/news/1118481158?lang=&edition=full_marsco","pubTime":"2021-09-15 19:02","market":"us","language":"en","title":"These 4 Stocks Are Netting Warren Buffett a Combined $3.1 Billion in Annual Dividend Income","url":"https://stock-news.laohu8.com/highlight/detail?id=1118481158","media":"Motley Fool","summary":"More than half of Berkshire Hathaway's dividend payouts are generated from four holdings.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Dividend stocks have played a key role in the Oracle of Omaha's long-term success.</li>\n <li>Collectively, these four holdings will pay out a little over $3.1 billion in dividend income to Buffett's company over the next year.</li>\n</ul>\n<p></p>\n<p>Few if any investors have been as successful over the long run as&nbsp;<b>Berkshire Hathaway</b>'s&nbsp;(NYSE:BRK.A)(NYSE:BRK.B)Warren Buffett. Since taking over as CEO in 1965, he's led his company's stock to an&nbsp;annual average return of 20%. Including the year-to-date return of the Class A shares (BRK.A), we're talking about an aggregate gain approaching 3,400,000%.</p>\n<p>There are&nbsp;a number of reasons&nbsp;Buffett is a successful investor. For example, he buys stakes in businesses he understands well, and he often focuses on companies that have clear and sustainable competitive advantages. However, the biggest puzzle piece to the Oracle of Omaha's success might be his affinity for&nbsp;dividend stocks.</p>\n<p>This year, Berkshire Hathaway is set to collect more than $5 billion in dividend income. Of this more than $5 billion, Buffett and his investing team will receive a little over $3.1 billion from just four stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b0127a7236d64db02cb47145f25e2ec9\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>BERKSHIRE HATHAWAY CEO WARREN BUFFETT. IMAGE SOURCE: THE MOTLEY FOOL.</span></p>\n<p><b>Bank of America: $867,595,685 in annual dividend income</b></p>\n<p>Buffett's golden goose on the dividend front is money-center behemoth&nbsp;<b>Bank of America</b>(NYSE:BAC). With over 1 billion shares held in Berkshire Hathaway's portfolio, the $0.84 base annual payout from BofA will yield almost $868 million in&nbsp;dividend income&nbsp;over the next 12 months.</p>\n<p>Bank of America is what you might call the prototypical Buffett stock. Like most bank stocks, it's a cyclical company that's primed to benefit from long periods of economic expansion. Even though recessions are an inevitable part of the economic cycle, they usually only last a few months or a couple of quarters. By comparison, periods of expansion are measured in years and allow BofA's bread-and-butter growth segments, such as loans and deposits, to thrive.</p>\n<p>What makes Bank of America such an intriguing investment at the moment is its interest-rate sensitivity. No money-center bank sees its interest income potential move up or down more because of changes in the interest rate yield curve. According to the company, a 100-basis-point parallel shift in the interest rate yield curve&nbsp;would add an estimated $8 billion in net interest income&nbsp;over 12 months. When rates inevitably do rise, this added net interest income will go straight to its bottom line.</p>\n<p>As one final note, Bank of America has done an excellent job with its digitization efforts. With more people than ever banking online or through mobile apps, BofA has been able to consolidate some of its branches and improve its operating performance.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d62012b118a588b5ce165ba9e6e12a9a\" tg-width=\"2000\" tg-height=\"1300\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>Occidental Petroleum (preferred shares): $800,000,000 in annual dividend income</b></p>\n<p>Though you won't see it listed in Berkshire Hathaway's portfolio, Buffett's company owns $10 billion worth of preferred stock from oil and gas company&nbsp;<b>Occidental Petroleum</b>(NYSE:OXY).</p>\n<p>Back in 2019, Berkshire Hathaway provided $10 billion in financing to allow Occidental to acquire Anadarko Petroleum, which was also being courted by integrated oil and gas giant&nbsp;<b>Chevron</b>. In return for handing over $10 billion, Buffett's company was granted 100,000 preferred shares of Occidental Petroleum stock, each with a value of $100,000. Most importantly, these preferred shares yield a cool 8% annually. Although&nbsp;it remains Occidental's prerogative&nbsp;whether this dividend is paid in cash or with issued shares of Occidental Petroleum stock, Buffett and his team have the option of collecting this payout for at least a decade.</p>\n<p>It should be noted that this deal also carries warrants to purchase up to 80 million shares of Occidental Petroleum stock at $62.50 per share. Although Occidental's share price is well below this mark at the moment, a sustainable rebound in oil prices and a&nbsp;successful deleveraging of its balance sheet&nbsp;might make these warrants worthwhile years down the road.</p>\n<p>Despite Buffett and his team selling their common stock holdings in Occidental Petroleum, it's pretty evident they have no desire to part ways with this inflation-topping return of 8% each year from the preferred shares.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/444424b2704605c7e9e9c80e1827f6a7\" tg-width=\"2000\" tg-height=\"1324\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: APPLE.</span></p>\n<p><b>Apple: $798,652,590 in annual dividend income</b></p>\n<p>Berkshire Hathaway's so-called \"third business\" is another source of big-time dividend income. Innovation kingpin&nbsp;<b>Apple</b>(NASDAQ:AAPL), the&nbsp;largest holding by far in Buffett's portfolio, is netting Berkshire almost $799 million annually.</p>\n<p>Apple's success is a reflection of consumers' incredible loyalty to the company, its dominance in certain categories, and its innovation. For instance, it's the most dominant provider of smartphones in the United States. According to Counterpoint Research, iPhone sales have accounted for between 53% and 65% of all U.S. smartphone share over the past three quarters. That's more than double its next closest competitor,<b>Samsung</b>. Not surprisingly, customer lines often wrap around Apple's stores when new products are launched.</p>\n<p>However,the future for Apple lies with its services and subscriptions. CEO Tim Cook is overseeing a long-term transition that'll emphasize these higher-margin platforms. Ultimately, services should reduce the revenue lumpiness associated with product cycles and improve long-term operating margins.</p>\n<p>What often gets overlooked with Apple is what a capital return superstar it's been. Since reintroducing a quarterly dividend in the summer of 2012, Apple has increased its payout by 132%. What's more, Apple spent in the neighborhood of $380 billion repurchasing 10.6 billion shares of its own common stock since commencing its share repurchase program in 2013. In other words, Apple's shareholders are getting rewarded in a multitude of ways.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f64dcdff17a24b8a4e277db734557537\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: COCA-COLA.</span></p>\n<p><b>Coca-Cola: $672,000,000 in annual dividend income</b></p>\n<p>The fourth and final Buffett stock that's contributing a boatload of dividend income each year is beverage company&nbsp;<b>Coca-Cola</b>(NYSE:KO). Coke is&nbsp;Buffett's longest-tenured holding, at 33 years.</p>\n<p>Coca-Cola's consistent and growing profitability is a function of a couple of factors. First, it's working with incredible geographic diversity. With the exception of North Korea and Cuba, Coke sells its products in every other country around the world. This means a recession in a few countries won't necessarily hurt its profit potential.</p>\n<p>To build on this point, Coca-Cola also possesses a 20% share of the cold-beverage market in developed markets, along with a 10% share of cold beverages sold in emerging markets. This position allows it to generate plenty of predictable cash flow from developed markets while leaning on the faster growth potential of developing markets. All told, the company has more than 20 global brands bringing in at least $1 billion in annual sales.</p>\n<p>Coke's global brand awareness is tough to beat, as well. It's&nbsp;one of the most recognized brands in the world&nbsp;and has historically had little issue crossing generational gaps to reach consumers. With everything from holiday tie-ins to social media marketing at its disposal, Coke is as steady as they come in the profit department. Perhaps that's why it's raised its base annual payout for 59 consecutive years.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Stocks Are Netting Warren Buffett a Combined $3.1 Billion in Annual Dividend Income</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Stocks Are Netting Warren Buffett a Combined $3.1 Billion in Annual Dividend Income\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-15 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/15/4-stocks-warren-buffett-3-billion-dividend-income/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nDividend stocks have played a key role in the Oracle of Omaha's long-term success.\nCollectively, these four holdings will pay out a little over $3.1 billion in dividend income to Buffett's...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/15/4-stocks-warren-buffett-3-billion-dividend-income/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/09/15/4-stocks-warren-buffett-3-billion-dividend-income/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118481158","content_text":"Key Points\n\nDividend stocks have played a key role in the Oracle of Omaha's long-term success.\nCollectively, these four holdings will pay out a little over $3.1 billion in dividend income to Buffett's company over the next year.\n\n\nFew if any investors have been as successful over the long run as Berkshire Hathaway's (NYSE:BRK.A)(NYSE:BRK.B)Warren Buffett. Since taking over as CEO in 1965, he's led his company's stock to an annual average return of 20%. Including the year-to-date return of the Class A shares (BRK.A), we're talking about an aggregate gain approaching 3,400,000%.\nThere are a number of reasons Buffett is a successful investor. For example, he buys stakes in businesses he understands well, and he often focuses on companies that have clear and sustainable competitive advantages. However, the biggest puzzle piece to the Oracle of Omaha's success might be his affinity for dividend stocks.\nThis year, Berkshire Hathaway is set to collect more than $5 billion in dividend income. Of this more than $5 billion, Buffett and his investing team will receive a little over $3.1 billion from just four stocks.\nBERKSHIRE HATHAWAY CEO WARREN BUFFETT. IMAGE SOURCE: THE MOTLEY FOOL.\nBank of America: $867,595,685 in annual dividend income\nBuffett's golden goose on the dividend front is money-center behemoth Bank of America(NYSE:BAC). With over 1 billion shares held in Berkshire Hathaway's portfolio, the $0.84 base annual payout from BofA will yield almost $868 million in dividend income over the next 12 months.\nBank of America is what you might call the prototypical Buffett stock. Like most bank stocks, it's a cyclical company that's primed to benefit from long periods of economic expansion. Even though recessions are an inevitable part of the economic cycle, they usually only last a few months or a couple of quarters. By comparison, periods of expansion are measured in years and allow BofA's bread-and-butter growth segments, such as loans and deposits, to thrive.\nWhat makes Bank of America such an intriguing investment at the moment is its interest-rate sensitivity. No money-center bank sees its interest income potential move up or down more because of changes in the interest rate yield curve. According to the company, a 100-basis-point parallel shift in the interest rate yield curve would add an estimated $8 billion in net interest income over 12 months. When rates inevitably do rise, this added net interest income will go straight to its bottom line.\nAs one final note, Bank of America has done an excellent job with its digitization efforts. With more people than ever banking online or through mobile apps, BofA has been able to consolidate some of its branches and improve its operating performance.\nIMAGE SOURCE: GETTY IMAGES.\nOccidental Petroleum (preferred shares): $800,000,000 in annual dividend income\nThough you won't see it listed in Berkshire Hathaway's portfolio, Buffett's company owns $10 billion worth of preferred stock from oil and gas company Occidental Petroleum(NYSE:OXY).\nBack in 2019, Berkshire Hathaway provided $10 billion in financing to allow Occidental to acquire Anadarko Petroleum, which was also being courted by integrated oil and gas giant Chevron. In return for handing over $10 billion, Buffett's company was granted 100,000 preferred shares of Occidental Petroleum stock, each with a value of $100,000. Most importantly, these preferred shares yield a cool 8% annually. Although it remains Occidental's prerogative whether this dividend is paid in cash or with issued shares of Occidental Petroleum stock, Buffett and his team have the option of collecting this payout for at least a decade.\nIt should be noted that this deal also carries warrants to purchase up to 80 million shares of Occidental Petroleum stock at $62.50 per share. Although Occidental's share price is well below this mark at the moment, a sustainable rebound in oil prices and a successful deleveraging of its balance sheet might make these warrants worthwhile years down the road.\nDespite Buffett and his team selling their common stock holdings in Occidental Petroleum, it's pretty evident they have no desire to part ways with this inflation-topping return of 8% each year from the preferred shares.\nIMAGE SOURCE: APPLE.\nApple: $798,652,590 in annual dividend income\nBerkshire Hathaway's so-called \"third business\" is another source of big-time dividend income. Innovation kingpin Apple(NASDAQ:AAPL), the largest holding by far in Buffett's portfolio, is netting Berkshire almost $799 million annually.\nApple's success is a reflection of consumers' incredible loyalty to the company, its dominance in certain categories, and its innovation. For instance, it's the most dominant provider of smartphones in the United States. According to Counterpoint Research, iPhone sales have accounted for between 53% and 65% of all U.S. smartphone share over the past three quarters. That's more than double its next closest competitor,Samsung. Not surprisingly, customer lines often wrap around Apple's stores when new products are launched.\nHowever,the future for Apple lies with its services and subscriptions. CEO Tim Cook is overseeing a long-term transition that'll emphasize these higher-margin platforms. Ultimately, services should reduce the revenue lumpiness associated with product cycles and improve long-term operating margins.\nWhat often gets overlooked with Apple is what a capital return superstar it's been. Since reintroducing a quarterly dividend in the summer of 2012, Apple has increased its payout by 132%. What's more, Apple spent in the neighborhood of $380 billion repurchasing 10.6 billion shares of its own common stock since commencing its share repurchase program in 2013. In other words, Apple's shareholders are getting rewarded in a multitude of ways.\nIMAGE SOURCE: COCA-COLA.\nCoca-Cola: $672,000,000 in annual dividend income\nThe fourth and final Buffett stock that's contributing a boatload of dividend income each year is beverage company Coca-Cola(NYSE:KO). Coke is Buffett's longest-tenured holding, at 33 years.\nCoca-Cola's consistent and growing profitability is a function of a couple of factors. First, it's working with incredible geographic diversity. With the exception of North Korea and Cuba, Coke sells its products in every other country around the world. This means a recession in a few countries won't necessarily hurt its profit potential.\nTo build on this point, Coca-Cola also possesses a 20% share of the cold-beverage market in developed markets, along with a 10% share of cold beverages sold in emerging markets. This position allows it to generate plenty of predictable cash flow from developed markets while leaning on the faster growth potential of developing markets. All told, the company has more than 20 global brands bringing in at least $1 billion in annual sales.\nCoke's global brand awareness is tough to beat, as well. It's one of the most recognized brands in the world and has historically had little issue crossing generational gaps to reach consumers. With everything from holiday tie-ins to social media marketing at its disposal, Coke is as steady as they come in the profit department. Perhaps that's why it's raised its base annual payout for 59 consecutive years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":938,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886918874,"gmtCreate":1631543155898,"gmtModify":1676530571570,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886918874","repostId":"1170383544","repostType":4,"repost":{"id":"1170383544","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631542185,"share":"https://ttm.financial/m/news/1170383544?lang=&edition=full_marsco","pubTime":"2021-09-13 22:09","market":"us","language":"en","title":"Hot chinese concept stocks dipped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1170383544","media":"Tiger Newspress","summary":"Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RL","content":"<p>Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RLX Technology&nbsp;and&nbsp;Tencent music&nbsp;between 1% and 9%.</p>\n<p><img src=\"https://static.tigerbbs.com/634dbf9be8ba7edcb7ca8b9b2e7f1e6a\" tg-width=\"362\" tg-height=\"715\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hot chinese concept stocks dipped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHot chinese concept stocks dipped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-13 22:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RLX Technology&nbsp;and&nbsp;Tencent music&nbsp;between 1% and 9%.</p>\n<p><img src=\"https://static.tigerbbs.com/634dbf9be8ba7edcb7ca8b9b2e7f1e6a\" tg-width=\"362\" tg-height=\"715\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TME":"腾讯音乐","RLX":"雾芯科技","BABA":"阿里巴巴","DIDI":"滴滴(已退市)","BIDU":"百度","PDD":"拼多多"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170383544","content_text":"Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RLX Technology and Tencent music between 1% and 9%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888936264,"gmtCreate":1631420397058,"gmtModify":1676530545355,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/888936264","repostId":"1189654544","repostType":4,"repost":{"id":"1189654544","kind":"news","pubTimestamp":1631406130,"share":"https://ttm.financial/m/news/1189654544?lang=&edition=full_marsco","pubTime":"2021-09-12 08:22","market":"us","language":"en","title":"US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1189654544","media":"Renaissance Capital","summary":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i","content":"<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.</p>\n<p>Tech consultancy&nbsp;<b>Thoughtworks</b>(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.</p>\n<p>Swiss running shoe brand&nbsp;<b>On Holding</b>(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.</p>\n<p>After ending talks to go public via SPAC,<b>Sportradar Group</b>(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.</p>\n<p>Drive-thru coffee chain&nbsp;<b>Dutch Bros</b>(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.</p>\n<p>Healthcare intelligence platform&nbsp;<b>Definitive Healthcare</b>(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.</p>\n<p>Identity management platform&nbsp;<b>ForgeRock</b>(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.</p>\n<p>Immunology biotech&nbsp;<b>DICE Therapeutics</b>(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.</p>\n<p>Surgical robotics developer&nbsp;<b>PROCEPT BioRobotics</b>(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.</p>\n<p>Oncology biotech&nbsp;<b>Tyra Biosciences</b>(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.</p>\n<p>Micro-cap gas delivery service&nbsp;<b>EzFill Holdings</b>(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.</p>\n<p><img src=\"https://static.tigerbbs.com/718698ff98644c4026f32efe91d076c6\" tg-width=\"1128\" tg-height=\"684\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/97fe13300d9e4cf61effc59b9706776a\" tg-width=\"1129\" tg-height=\"247\" referrerpolicy=\"no-referrer\"></p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&amp;P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 08:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWKS":"Thoughtworks Holding Inc.",".SPX":"S&P 500 Index","ONON":"On Holding AG","FORG":"ForgeRock, Inc.","BROS":"Dutch Bros Inc.","DICE":"DICE Therapeutics, Inc.","TYRA":"Tyra Biosciences, Inc.","PRCT":"PROCEPT BioRobotics",".DJI":"道琼斯","SRAD":"Sportradar Group AG",".IXIC":"NASDAQ Composite","DH":"Definitive Healthcare Corp."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189654544","content_text":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.\nSwiss running shoe brand On Holding(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.\nAfter ending talks to go public via SPAC,Sportradar Group(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.\nDrive-thru coffee chain Dutch Bros(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.\nHealthcare intelligence platform Definitive Healthcare(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.\nIdentity management platform ForgeRock(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.\nImmunology biotech DICE Therapeutics(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.\nSurgical robotics developer PROCEPT BioRobotics(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.\nOncology biotech Tyra Biosciences(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.\nMicro-cap gas delivery service EzFill Holdings(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.\n\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1594,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881981722,"gmtCreate":1631285279066,"gmtModify":1676530520614,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/881981722","repostId":"1101890813","repostType":4,"repost":{"id":"1101890813","kind":"news","pubTimestamp":1631263267,"share":"https://ttm.financial/m/news/1101890813?lang=&edition=full_marsco","pubTime":"2021-09-10 16:41","market":"us","language":"en","title":"How Will The Debt Limit Drama Play Out: Here Are The Two Scenarios","url":"https://stock-news.laohu8.com/highlight/detail?id=1101890813","media":"zerohedge","summary":"Addressing a topic that could soon become a big concern for the bond market - the October dead limit","content":"<p>Addressing a topic that could soon become a big concern for the bond market - the October dead limit deadline -&nbsp; Curvature's repo expert Scott Skyrmsaid this morningthat, \"for the past several years, Congress always reached a compromise before the possibility of a \"technical default\" creeped into the markets. This year, as we get closer to the \"drop dead date\" (which hasn't yet been determined) the markets will start pricing in distortions.\"</p>\n<p>To this we can add that as we noted yesterday, distortions in the bond market are already clearly emerging, with the spread between October and November -<i>this is where the market estimates the \"drop dead date\" will take place</i>- T-Bills rising fast:</p>\n<p><img src=\"https://static.tigerbbs.com/18baa5bfc2f4fcada29a0e71d4887b7e\" tg-width=\"1024\" tg-height=\"528\" width=\"100%\" height=\"auto\">The next chart shows that the T-Bill curve is clearly moving wider around the early November timeframe.</p>\n<p><img src=\"https://static.tigerbbs.com/e688a9eb195944fe7e906a13a6319b8f\" tg-width=\"963\" tg-height=\"581\" width=\"100%\" height=\"auto\">As a reminder, yesterday Treasury Secretary Yellen sent a letter to congressional leaders this morning indicating that the the Treasury will exhaust its cash and extraordinary measures \"during the month of October\". This slightly sooner than the \"October or November\" timing that the Congressional Budget Office had estimated in a report in late July.</p>\n<p>So how will the upcoming debt limit drama play out?<i>According to Goldman, there are several possible scenarios from here</i>:</p>\n<p>The most likely scenario is that Democratic leaders will attach a debt limit suspension to upcoming spending legislation to keep the federal government open past the end of the fiscal year (a \"continuing resolution\") and to provide emergency disaster relief funding related to the fires in the Western US and storm damage in the East and South.&nbsp;<b>As 46 Senate Republicans have indicated they will block a debt limit increase, there is a good chance this strategy will not succeed.</b>That said, passage of short-term debt limit might be possible as several Republican senators represent states affected by recent disasters.&nbsp; One option Republicans might consider would be to vote against the bill but decline to filibuster it, allowing it to pass with only 51 votes in the Senate. This would likely require unanimous Democratic support in that chamber, which is possible but not certain.</p>\n<p>If Senate Republicans block the spending bill later this month,<b>Democratic leaders would then need to decide whether to force the issue and risk a partial federal government shutdown, or to remove the debt limit suspension from the spending bill.</b>If lawmakers end in a stalemate, a government shutdown might follow, though Goldman does not see this as the base case.</p>\n<p>If they are unable to raise the debt limit as part of a spending bill, they might consider using the reconciliation process to pass it with only 51 votes.<b>However, this faces two challenges:</b></p>\n<ul>\n <li><b>First, it is unclear whether all Senate Democrats would vote for a revised budget resolution that increases the debt limit by several trillion dollars</b>. if Democrats use the reconciliation process, Senate rules would probably allow them only to raise the debt limit by a specific dollar figure,<b>which would lead to more politically problematic headlines, rather than suspend it for a period of time, which has become the norm over the last decade as it does not lead to a specific dollar amount at the time of passage</b>.</li>\n <li><b>Second, the current reconciliation process to pass as much as $3.5 trillion in new spending is already underway, with House committees already in the process of considering and passing their segments of the bill in committee</b>. Revising the budget resolution, which governs that process, could interfere with consideration of that legislation, and would likely take at least a couple of weeks, if not longer.<b>If Democrats wait until Sep. 30 to test support for a debt limit increase as part of the spending bill, they might not have sufficient time to go through all of the procedures necessary to revise the resolution before the debt limit deadline.</b></li>\n</ul>\n<p>In other words, as on every prior occasion when the debt limit was raised or extended in the last possible minute, this time is unlikely to be an exception - after all the alternative is a catastrophic outcome for the US. However, the longer Congress waits the more challenging the debt limit process becomes, and could be thrown for a loop if one or more holdouts block the process in the last minute, unleashing chaos in the market if only to provoke politicians into action. As we get closer to the D-Day, keep an eye on the spread in T-Bills for an indication of just how nervous the market is becoming.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Will The Debt Limit Drama Play Out: Here Are The Two Scenarios</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Will The Debt Limit Drama Play Out: Here Are The Two Scenarios\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 16:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/how-will-debt-limit-drama-play-out-here-are-two-scenarios><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Addressing a topic that could soon become a big concern for the bond market - the October dead limit deadline -  Curvature's repo expert Scott Skyrmsaid this morningthat, \"for the past several years, ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/how-will-debt-limit-drama-play-out-here-are-two-scenarios\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.zerohedge.com/markets/how-will-debt-limit-drama-play-out-here-are-two-scenarios","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101890813","content_text":"Addressing a topic that could soon become a big concern for the bond market - the October dead limit deadline -  Curvature's repo expert Scott Skyrmsaid this morningthat, \"for the past several years, Congress always reached a compromise before the possibility of a \"technical default\" creeped into the markets. This year, as we get closer to the \"drop dead date\" (which hasn't yet been determined) the markets will start pricing in distortions.\"\nTo this we can add that as we noted yesterday, distortions in the bond market are already clearly emerging, with the spread between October and November -this is where the market estimates the \"drop dead date\" will take place- T-Bills rising fast:\nThe next chart shows that the T-Bill curve is clearly moving wider around the early November timeframe.\nAs a reminder, yesterday Treasury Secretary Yellen sent a letter to congressional leaders this morning indicating that the the Treasury will exhaust its cash and extraordinary measures \"during the month of October\". This slightly sooner than the \"October or November\" timing that the Congressional Budget Office had estimated in a report in late July.\nSo how will the upcoming debt limit drama play out?According to Goldman, there are several possible scenarios from here:\nThe most likely scenario is that Democratic leaders will attach a debt limit suspension to upcoming spending legislation to keep the federal government open past the end of the fiscal year (a \"continuing resolution\") and to provide emergency disaster relief funding related to the fires in the Western US and storm damage in the East and South. As 46 Senate Republicans have indicated they will block a debt limit increase, there is a good chance this strategy will not succeed.That said, passage of short-term debt limit might be possible as several Republican senators represent states affected by recent disasters.  One option Republicans might consider would be to vote against the bill but decline to filibuster it, allowing it to pass with only 51 votes in the Senate. This would likely require unanimous Democratic support in that chamber, which is possible but not certain.\nIf Senate Republicans block the spending bill later this month,Democratic leaders would then need to decide whether to force the issue and risk a partial federal government shutdown, or to remove the debt limit suspension from the spending bill.If lawmakers end in a stalemate, a government shutdown might follow, though Goldman does not see this as the base case.\nIf they are unable to raise the debt limit as part of a spending bill, they might consider using the reconciliation process to pass it with only 51 votes.However, this faces two challenges:\n\nFirst, it is unclear whether all Senate Democrats would vote for a revised budget resolution that increases the debt limit by several trillion dollars. if Democrats use the reconciliation process, Senate rules would probably allow them only to raise the debt limit by a specific dollar figure,which would lead to more politically problematic headlines, rather than suspend it for a period of time, which has become the norm over the last decade as it does not lead to a specific dollar amount at the time of passage.\nSecond, the current reconciliation process to pass as much as $3.5 trillion in new spending is already underway, with House committees already in the process of considering and passing their segments of the bill in committee. Revising the budget resolution, which governs that process, could interfere with consideration of that legislation, and would likely take at least a couple of weeks, if not longer.If Democrats wait until Sep. 30 to test support for a debt limit increase as part of the spending bill, they might not have sufficient time to go through all of the procedures necessary to revise the resolution before the debt limit deadline.\n\nIn other words, as on every prior occasion when the debt limit was raised or extended in the last possible minute, this time is unlikely to be an exception - after all the alternative is a catastrophic outcome for the US. However, the longer Congress waits the more challenging the debt limit process becomes, and could be thrown for a loop if one or more holdouts block the process in the last minute, unleashing chaos in the market if only to provoke politicians into action. As we get closer to the D-Day, keep an eye on the spread in T-Bills for an indication of just how nervous the market is becoming.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1049,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880883911,"gmtCreate":1631031311233,"gmtModify":1676530448991,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880883911","repostId":"1130130857","repostType":4,"repost":{"id":"1130130857","kind":"news","pubTimestamp":1631007146,"share":"https://ttm.financial/m/news/1130130857?lang=&edition=full_marsco","pubTime":"2021-09-07 17:32","market":"us","language":"en","title":"Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=1130130857","media":"Barron's","summary":"What a year this has been for the markets!Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and  a mostly receding pandemic, theS&P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.Tailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnin","content":"<p>What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&amp;P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.</p>\n<p>Tailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnings growth are likely to decelerate through the end of the year. What’s more, theFederal Reserve has all but promised to start tapering its bond buyingin coming months, and the Biden administration has proposed hiking corporate and personal tax rates. None of this is apt to sit well with holders of increasingly pricey shares.</p>\n<p>In other words,brace for a volatile fallin which conflicting forces buffet stocks, bonds, and investors. “The everything rally is behind us,” says Saira Malik, chief investment officer of global equities at Nuveen. “It’s not going to be a sharply rising economic tide that lifts all boats from here.”</p>\n<p>That’s the general consensus among the six market strategists and chief investment officers whom<i>Barron’s</i>recently consulted. All see the S&amp;P 500 ending the year near Thursday’s close of 4536. Their average target: 4585.</p>\n<p>Next year’s gains look muted, as well, relative to recent trends. The group expects the S&amp;P 500 to tack on another 6% in 2022, rising to about 4800.</p>\n<p><img src=\"https://static.tigerbbs.com/eb61c7b74b9b0f18a019afb4ac44ad59\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">With stocks trading for about 21 times the coming year’s expected earnings,bonds yielding little, and cash yielding less than nothing after accounting for inflation, investors face tough asset-allocation decisions. In place of the “everything rally,” which lifted fast-growing tech stocks, no-growth meme stocks, and the Dogecoins of the digital world, our market watchers recommend focusing on “quality” investments. In equities, that means shares of businesses with solid balance sheets, expanding profit margins, and ample and recurring free cash flow. Even if the averages do little in coming months, these stocks are likely to shine.</p>\n<p>The stock market’s massive rally in the past year was a gift of sorts from the Federal Reserve, which flooded the financial system with money to stave off theeconomic damage wrought by the Covid pandemic. Since March 2020, the U.S. central bank has been buying a combined $120 billion a month of U.S. Treasuries and mortgage-backed securities, while keeping its benchmark federal-funds rate target at 0% to 0.25%. These moves have depressed bond yields and pushed investors into riskier assets, including stocks.</p>\n<p>Fed Chairman Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> has said that the central bank might begin to wind down, or taper, its emergency asset purchases sometime in the coming quarters, a move that could roil risk assets of all sorts. “For us, it’s very simple: Tapering is tightening,” says Mike Wilson, chief investment officer and chief U.S. equity strategist atMorgan Stanley.“It’s the first step away from maximum accommodation [by the Fed]. They’re being very calculated about it this time, but the bottom line is that it should have a negative effect on equity valuations.”</p>\n<p>The government’s stimulus spending, too, has peaked, the strategists note. Supplemental federal unemployment benefits of $300 a week expire as of Sept. 6. Although Congress seems likely to pass a bipartisan infrastructure bill this fall, the near-term economic impact will pale in comparison to the multiple rounds of stimulus introduced since March 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/c2cb76c498c1c4c980139e3d0514c261\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">The bill includes about $550 billion in new spending—a fraction of the trillions authorized by previous laws—and it will be spread out over many years. The short-term boost that infrastructure stimulus will give to consumer spending, which accounts for almost 70% of U.S. growth domestic product, won’t come close to what the economy saw after millions of Americans received checks from the government this past year.</p>\n<p>A budget bill approved by Democrats only should follow the infrastructure bill, and include spending to support Medicare expansion, child-care funding, free community-college tuition, public housing, and climate-related measures, among other party priorities. Congress could vote to lift taxes on corporations and high-earning individuals to offset that spending—another near-term risk to the market.</p>\n<p><img src=\"https://static.tigerbbs.com/6693da658db16059fc99e08a7531675f\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">Other politically charged issues likewise could derail equities this fall. Congress needs to pass a debt-ceiling increase to fund the government, and a stop-gap spending bill later this month to avoid a <a href=\"https://laohu8.com/S/WASH\">Washington</a> shutdown in October.</p>\n<p>For now, our market experts are relatively sanguine about the economic impact of the Delta variant of Covid-19. As long as vaccines remain effective in minimizing severe infections that lead to hospitalizations and deaths, the negative effects of the current Covid wave will be limited largely to the travel industry and movie theaters, they say. Wall Street’s base case for the market doesn’t include a renewed wave of lockdowns that would undermine economic growth.</p>\n<p>Inflation has been a hot topic at the Fed and among investors, partly because it has been running so hot of late. The U.S. consumer price index rose at an annualized 5.4% in both June and July—a spike the Fed calls transitory, although others aren’t so sure. The strategists are taking Powell’s side of the argument; they expect inflation to fall significantly next year. Their forecasts fall between 2.5% and 3.5%, which they consider manageable for consumers and companies, and an acceptable side effect of rapid economic growth. An inflation rate above 2.5%, however, combined with Fed tapering, would mean that now ultralow bond yields should rise.</p>\n<p>“We think inflation will continue to run hotter than it has since the financial crisis, but it’s hard for us to see inflation much over 2.5% once many of the reopening-related pressures start to dissipate,” says Michael Fredericks, head of income investing for theBlackRockMulti-Asset Strategies Group. “So bond yields do need to move up, but that will happen gradually.”</p>\n<p>The strategists see the yield on the 10-year U.S. Treasury note climbing to around 1.65% by year end. That’s about 35 basis points—or hundredths of a percentage point—above current levels, but below the 1.75% that the yield reached at its March 2021 highs. By next year, the 10-year Treasury could yield 2%, the group says. Those aren’t big moves in absolute terms, but they’re meaningful for&nbsp;the bond market—and could be even more so for stocks.</p>\n<p>Rising yields tend to weigh on stock valuations for two reasons. Higher-yielding bonds offer competition to stocks, and companies’ future earnings are worthless in the present when discounting them at a higher rate. Still, a 10-year yield around 2% won’t be enough to knock stock valuations down to pre-Covid levels. Even if yields climb, market strategists see the price/earnings multiple of the S&amp;P 500 holding well above its 30-year average of 16 times forward earnings. The index’s forward P/E topped 23 last fall.</p>\n<p><img src=\"https://static.tigerbbs.com/e08d24cb421d7cc13debd76a9c6fea01\" tg-width=\"660\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p>\n<p>As long as 10-year Treasury yields stay in the 2% range, the S&amp;P 500 should be able to command a forward P/E in the high teens, strategists say. A return to the 16-times long-term average isn’t in the cards until there is more pressure from much higher yields—or something else that causes stocks to fall.</p>\n<p>If yields surge past 2% or 2.25%, investors could start to question equity valuations more seriously, says&nbsp;<a href=\"https://laohu8.com/S/STT\">State</a> Street’schief portfolio strategist, Gaurav Mallik: “We haven’t seen [the 10-year yield] above 2% for some time now, so that’s an important sentiment level for investors.”</p>\n<p><img src=\"https://static.tigerbbs.com/93ff6490069ab5dc1b4057f1ff7966f3\" tg-width=\"664\" tg-height=\"441\" referrerpolicy=\"no-referrer\"></p>\n<p>Wilson is more concerned, noting that the stock market’s valuation risk is asymmetric: “It’s very unlikely that multiples are going to go up, and there’s a good chance that they go down more than 10% given the deceleration in growth and where we are in the cycle,” he says</p>\n<p>If 16 to 23 times forward earnings is the range, he adds, “you’re already at the very high end of that. There’s more potential risk than reward.”</p>\n<p>Some P/E-multiple compression is baked into all six strategists’ forecasts, heaping greater importance on the path of profit growth. On average, the strategists expect S&amp;P 500 earnings to jump 46% this year, to about $204, after last year’s earnings depression. That could be followed by a more normalized gain of 9% in 2022, to about $222.50.</p>\n<p>A potential headwind would be a higher federal corporate-tax rate in 2022. The details of Democrats’ spending and taxation plans will be worked out in the coming weeks, and investors can expect to hear a lot more about potential tax increases. Several strategists see a 25% federal rate on corporate profits as a likely compromise figure, above the 21% in place since 2018, but below the 28% sought by the Biden administration.</p>\n<p>An increase of that magnitude would shave about 5% off S&amp;P 500 earnings next year. The index could drop by a similar amount as the passage of the Democrats’ reconciliation bill nears this fall, but the impact should be limited to that initial correction. As with the tax cuts in December 2017, the change should be a <a href=\"https://laohu8.com/S/AONE.U\">one</a>-time event for the market, some strategists predict.</p>\n<p>These concerns aside, investors shouldn’t miss the bigger picture: The U.S. economy is in good shape and growing robustly. The strategists expect gross domestic product to rise 6.3% this year and about 4% in 2022. “The cyclical uplift and above-trend growth will continue at least through 2022, and we want to be biased toward assets that have that exposure,” says Mallik.</p>\n<blockquote>\n “We’re going to have a hot economy this year and next. When GDP growth is above average, value beats growth and cyclicals beat defensives.”— Lori Calvasina, RBC Capital Markets\n</blockquote>\n<p>The State Street strategist recommends overweighting materials, financials, and technology in investment portfolios. That approach includes both economically sensitive companies, such as banks and miners, and steady growers in the tech sector.</p>\n<p>RBC Capital Markets’ head of U.S. equity strategy, Lori Calvasina, likewise takes a barbell approach, with both cyclical and growth exposure. Her preferred sectors are energy, financials, and technology.</p>\n<p>“Valuations are still a lot more attractive in financials and energy than growth [sectors such as technology or consumer discretionary,]” Calvasina says. “The catalyst in the near term is getting out of the current Covid wave... We’re going to have a hot economy this year and next, and traditionally when GDP growth is above average, value beats growth and cyclicals beat defensives.”</p>\n<p>But the focus on quality will be pivotal, especially moving into the second half of 2022. That’s when the Fed is likely to hike interest rates for the first time in this cycle. By 2023, the economy could return to pre-Covid growth on the order of 2%.</p>\n<p>“The historical playbook is that coming out of a recession, you tend to see low-quality outperformance that lasts about a year, then leadership flips back to high quality,” Calvasina says. “But that transition from low quality back to high quality tends to be very bumpy.”</p>\n<p><b>A Shopping List for Fall</b></p>\n<p>Most strategists favor a combination of economically sensitive stocks and steady growers, including tech shares. Financials should do well, particularly if bond yields rise.</p>\n<p><img src=\"https://static.tigerbbs.com/a54c4bd114c1a5f7f700d1fc14d30d8e\" tg-width=\"970\" tg-height=\"230\" referrerpolicy=\"no-referrer\"></p>\n<p>Although stocks with quality attributes have outperformed the market this summer, according to a <a href=\"https://laohu8.com/S/BLK\">BlackRock</a> analysis, the quality factor has lagged since positive vaccine news was first reported last November.</p>\n<p>“We’re moving into a mid-cycle environment, when underlying economic growth remains strong but momentum begins to decelerate,” BlackRock’s Fredericks says. “Our research shows that quality stocks perform particularly well in such a period.”</p>\n<p>He recommends overweighting profitable technology companies; financials, including banks, and consumer staples and industrials with those quality characteristics.</p>\n<p>For <a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a>’s head of equity strategy, Christopher Harvey, a mix of post-pandemic beneficiaries and defensive exposure is the way to go. He constructed a basket of stocks with lower-than-average volatility—which should outperform during periods of market uncertainty or stress this fall—and high “Covid beta,” or sensitivity to good or bad news about the pandemic. One requirement; The stocks had to be rated the equivalent of Buy by Wells Fargo’s equity analysts.</p>\n<p>“There’s near-term economic uncertainty, interest-rate uncertainty, and Covid risk, and generally we’re in a seasonally weaker part of the year around September,” says Harvey. “If we can balance low vol and high Covid beta, we can mitigate a lot of the upcoming uncertainty and volatility around timing of several of those catalysts. Longer-term, though, we still want to have that [reopening exposure.]”</p>\n<p>Harvey’s list of low-volatility stocks with high Covid beta includesApple(AAPL),<a href=\"https://laohu8.com/S/BAC\">Bank of America</a>(BAC),<a href=\"https://laohu8.com/S/NTRSP\">Northern</a> Trust(NTRS),Lowe’s(LOW),<a href=\"https://laohu8.com/S/IQV\">IQVIA</a> Holdings(IQV), andMasco(MAS).</p>\n<p>Overall, banks are the most frequently recommended group for the months ahead. TheInvesco KBW Bankexchange-traded fund (KBWB) provides broad exposure to the sector in the U.S.</p>\n<p>“We like the valuations [and] credit quality; they are now allowed to buy back shares and increase dividends, and there’s higher Covid beta,” says Harvey.</p>\n<p>Cheaper valuations mean less potential downside in a market correction. And, contrary to much of the rest of the stock market, higher interest rates would be a tailwind for the banks, which could then charge more for loans.</p>\n<p><a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> stocks also have some fans. “<a href=\"https://laohu8.com/S/HR\">Healthcare</a> has both defensive and growth attributes to it,” Wilson says. “You’re paying a lot less per unit of growth in healthcare today than you are in other sectors. So we think it provides good balance in this market when we’re worried about valuation.” Health insurerHumana(HUM) makes Wilson’s “Fresh Money Buy List” of stocks Buy-rated by <a href=\"https://laohu8.com/S/MS\">Morgan Stanley</a> analysts and fitting his macro views.</p>\n<p>Nuveen’s Malik is also looking toward health care for relatively underpriced growth exposure, namely in the pharmaceuticals and biotechnology groups. She points toSeagen(SGEN), which is focused on oncology drugs and could be an attractive acquisition target for a pharma giant.</p>\n<p>Malik also likesAbbVie(ABBV) which trades at an undemanding eight times forward earnings and sports a 4.7% dividend yield. The coming expiration of patents on its blockbuster anti-inflammatory drug Humira has kept some investors away, but Malik is confident that management can limit the damage and sees promising drugs in development at the $200 billion company.</p>\n<p>Both stocks have had a tough time in recent days. Seagen fell more than 8% last week, to around $152, on news that its co-founder and CEO sold a large number of shares recently. AndAbbVietanked 7% Wednesday, to $112.27, after the Food and Drug Administration required new warning labels for JAK inhibitors, a type of anti-rheumatoid drug that includes one of <a href=\"https://laohu8.com/S/ABBV\">AbbVie</a>’s most promising post-Humira products.</p>\n<p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>(PFE),<a href=\"https://laohu8.com/S/AXP\">American Express</a>(AXP),Johnson &amp; Johnson(JNJ), andCisco Systems(CSCO) are other S&amp;P 500 members that pass a<i>Barron’s</i>screen for quality attributes.</p>\n<p>After a year of steady gains, investors might be reminded this fall that stocks can also decline, as growth momentum and policy support begin to fade. But underlying economic strength supports buying the dip, should the market drop from its highs. <a href=\"https://laohu8.com/S/JE\">Just</a> be more selective. And go with quality.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStrategists Say the Stock Market Could Struggle This Fall. What to Buy Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 17:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&P 500stock index has...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF"},"source_url":"https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130130857","content_text":"What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.\nTailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnings growth are likely to decelerate through the end of the year. What’s more, theFederal Reserve has all but promised to start tapering its bond buyingin coming months, and the Biden administration has proposed hiking corporate and personal tax rates. None of this is apt to sit well with holders of increasingly pricey shares.\nIn other words,brace for a volatile fallin which conflicting forces buffet stocks, bonds, and investors. “The everything rally is behind us,” says Saira Malik, chief investment officer of global equities at Nuveen. “It’s not going to be a sharply rising economic tide that lifts all boats from here.”\nThat’s the general consensus among the six market strategists and chief investment officers whomBarron’srecently consulted. All see the S&P 500 ending the year near Thursday’s close of 4536. Their average target: 4585.\nNext year’s gains look muted, as well, relative to recent trends. The group expects the S&P 500 to tack on another 6% in 2022, rising to about 4800.\nWith stocks trading for about 21 times the coming year’s expected earnings,bonds yielding little, and cash yielding less than nothing after accounting for inflation, investors face tough asset-allocation decisions. In place of the “everything rally,” which lifted fast-growing tech stocks, no-growth meme stocks, and the Dogecoins of the digital world, our market watchers recommend focusing on “quality” investments. In equities, that means shares of businesses with solid balance sheets, expanding profit margins, and ample and recurring free cash flow. Even if the averages do little in coming months, these stocks are likely to shine.\nThe stock market’s massive rally in the past year was a gift of sorts from the Federal Reserve, which flooded the financial system with money to stave off theeconomic damage wrought by the Covid pandemic. Since March 2020, the U.S. central bank has been buying a combined $120 billion a month of U.S. Treasuries and mortgage-backed securities, while keeping its benchmark federal-funds rate target at 0% to 0.25%. These moves have depressed bond yields and pushed investors into riskier assets, including stocks.\nFed Chairman Jerome Powell has said that the central bank might begin to wind down, or taper, its emergency asset purchases sometime in the coming quarters, a move that could roil risk assets of all sorts. “For us, it’s very simple: Tapering is tightening,” says Mike Wilson, chief investment officer and chief U.S. equity strategist atMorgan Stanley.“It’s the first step away from maximum accommodation [by the Fed]. They’re being very calculated about it this time, but the bottom line is that it should have a negative effect on equity valuations.”\nThe government’s stimulus spending, too, has peaked, the strategists note. Supplemental federal unemployment benefits of $300 a week expire as of Sept. 6. Although Congress seems likely to pass a bipartisan infrastructure bill this fall, the near-term economic impact will pale in comparison to the multiple rounds of stimulus introduced since March 2020.\nThe bill includes about $550 billion in new spending—a fraction of the trillions authorized by previous laws—and it will be spread out over many years. The short-term boost that infrastructure stimulus will give to consumer spending, which accounts for almost 70% of U.S. growth domestic product, won’t come close to what the economy saw after millions of Americans received checks from the government this past year.\nA budget bill approved by Democrats only should follow the infrastructure bill, and include spending to support Medicare expansion, child-care funding, free community-college tuition, public housing, and climate-related measures, among other party priorities. Congress could vote to lift taxes on corporations and high-earning individuals to offset that spending—another near-term risk to the market.\nOther politically charged issues likewise could derail equities this fall. Congress needs to pass a debt-ceiling increase to fund the government, and a stop-gap spending bill later this month to avoid a Washington shutdown in October.\nFor now, our market experts are relatively sanguine about the economic impact of the Delta variant of Covid-19. As long as vaccines remain effective in minimizing severe infections that lead to hospitalizations and deaths, the negative effects of the current Covid wave will be limited largely to the travel industry and movie theaters, they say. Wall Street’s base case for the market doesn’t include a renewed wave of lockdowns that would undermine economic growth.\nInflation has been a hot topic at the Fed and among investors, partly because it has been running so hot of late. The U.S. consumer price index rose at an annualized 5.4% in both June and July—a spike the Fed calls transitory, although others aren’t so sure. The strategists are taking Powell’s side of the argument; they expect inflation to fall significantly next year. Their forecasts fall between 2.5% and 3.5%, which they consider manageable for consumers and companies, and an acceptable side effect of rapid economic growth. An inflation rate above 2.5%, however, combined with Fed tapering, would mean that now ultralow bond yields should rise.\n“We think inflation will continue to run hotter than it has since the financial crisis, but it’s hard for us to see inflation much over 2.5% once many of the reopening-related pressures start to dissipate,” says Michael Fredericks, head of income investing for theBlackRockMulti-Asset Strategies Group. “So bond yields do need to move up, but that will happen gradually.”\nThe strategists see the yield on the 10-year U.S. Treasury note climbing to around 1.65% by year end. That’s about 35 basis points—or hundredths of a percentage point—above current levels, but below the 1.75% that the yield reached at its March 2021 highs. By next year, the 10-year Treasury could yield 2%, the group says. Those aren’t big moves in absolute terms, but they’re meaningful for the bond market—and could be even more so for stocks.\nRising yields tend to weigh on stock valuations for two reasons. Higher-yielding bonds offer competition to stocks, and companies’ future earnings are worthless in the present when discounting them at a higher rate. Still, a 10-year yield around 2% won’t be enough to knock stock valuations down to pre-Covid levels. Even if yields climb, market strategists see the price/earnings multiple of the S&P 500 holding well above its 30-year average of 16 times forward earnings. The index’s forward P/E topped 23 last fall.\n\nAs long as 10-year Treasury yields stay in the 2% range, the S&P 500 should be able to command a forward P/E in the high teens, strategists say. A return to the 16-times long-term average isn’t in the cards until there is more pressure from much higher yields—or something else that causes stocks to fall.\nIf yields surge past 2% or 2.25%, investors could start to question equity valuations more seriously, says State Street’schief portfolio strategist, Gaurav Mallik: “We haven’t seen [the 10-year yield] above 2% for some time now, so that’s an important sentiment level for investors.”\n\nWilson is more concerned, noting that the stock market’s valuation risk is asymmetric: “It’s very unlikely that multiples are going to go up, and there’s a good chance that they go down more than 10% given the deceleration in growth and where we are in the cycle,” he says\nIf 16 to 23 times forward earnings is the range, he adds, “you’re already at the very high end of that. There’s more potential risk than reward.”\nSome P/E-multiple compression is baked into all six strategists’ forecasts, heaping greater importance on the path of profit growth. On average, the strategists expect S&P 500 earnings to jump 46% this year, to about $204, after last year’s earnings depression. That could be followed by a more normalized gain of 9% in 2022, to about $222.50.\nA potential headwind would be a higher federal corporate-tax rate in 2022. The details of Democrats’ spending and taxation plans will be worked out in the coming weeks, and investors can expect to hear a lot more about potential tax increases. Several strategists see a 25% federal rate on corporate profits as a likely compromise figure, above the 21% in place since 2018, but below the 28% sought by the Biden administration.\nAn increase of that magnitude would shave about 5% off S&P 500 earnings next year. The index could drop by a similar amount as the passage of the Democrats’ reconciliation bill nears this fall, but the impact should be limited to that initial correction. As with the tax cuts in December 2017, the change should be a one-time event for the market, some strategists predict.\nThese concerns aside, investors shouldn’t miss the bigger picture: The U.S. economy is in good shape and growing robustly. The strategists expect gross domestic product to rise 6.3% this year and about 4% in 2022. “The cyclical uplift and above-trend growth will continue at least through 2022, and we want to be biased toward assets that have that exposure,” says Mallik.\n\n “We’re going to have a hot economy this year and next. When GDP growth is above average, value beats growth and cyclicals beat defensives.”— Lori Calvasina, RBC Capital Markets\n\nThe State Street strategist recommends overweighting materials, financials, and technology in investment portfolios. That approach includes both economically sensitive companies, such as banks and miners, and steady growers in the tech sector.\nRBC Capital Markets’ head of U.S. equity strategy, Lori Calvasina, likewise takes a barbell approach, with both cyclical and growth exposure. Her preferred sectors are energy, financials, and technology.\n“Valuations are still a lot more attractive in financials and energy than growth [sectors such as technology or consumer discretionary,]” Calvasina says. “The catalyst in the near term is getting out of the current Covid wave... We’re going to have a hot economy this year and next, and traditionally when GDP growth is above average, value beats growth and cyclicals beat defensives.”\nBut the focus on quality will be pivotal, especially moving into the second half of 2022. That’s when the Fed is likely to hike interest rates for the first time in this cycle. By 2023, the economy could return to pre-Covid growth on the order of 2%.\n“The historical playbook is that coming out of a recession, you tend to see low-quality outperformance that lasts about a year, then leadership flips back to high quality,” Calvasina says. “But that transition from low quality back to high quality tends to be very bumpy.”\nA Shopping List for Fall\nMost strategists favor a combination of economically sensitive stocks and steady growers, including tech shares. Financials should do well, particularly if bond yields rise.\n\nAlthough stocks with quality attributes have outperformed the market this summer, according to a BlackRock analysis, the quality factor has lagged since positive vaccine news was first reported last November.\n“We’re moving into a mid-cycle environment, when underlying economic growth remains strong but momentum begins to decelerate,” BlackRock’s Fredericks says. “Our research shows that quality stocks perform particularly well in such a period.”\nHe recommends overweighting profitable technology companies; financials, including banks, and consumer staples and industrials with those quality characteristics.\nFor Wells Fargo’s head of equity strategy, Christopher Harvey, a mix of post-pandemic beneficiaries and defensive exposure is the way to go. He constructed a basket of stocks with lower-than-average volatility—which should outperform during periods of market uncertainty or stress this fall—and high “Covid beta,” or sensitivity to good or bad news about the pandemic. One requirement; The stocks had to be rated the equivalent of Buy by Wells Fargo’s equity analysts.\n“There’s near-term economic uncertainty, interest-rate uncertainty, and Covid risk, and generally we’re in a seasonally weaker part of the year around September,” says Harvey. “If we can balance low vol and high Covid beta, we can mitigate a lot of the upcoming uncertainty and volatility around timing of several of those catalysts. Longer-term, though, we still want to have that [reopening exposure.]”\nHarvey’s list of low-volatility stocks with high Covid beta includesApple(AAPL),Bank of America(BAC),Northern Trust(NTRS),Lowe’s(LOW),IQVIA Holdings(IQV), andMasco(MAS).\nOverall, banks are the most frequently recommended group for the months ahead. TheInvesco KBW Bankexchange-traded fund (KBWB) provides broad exposure to the sector in the U.S.\n“We like the valuations [and] credit quality; they are now allowed to buy back shares and increase dividends, and there’s higher Covid beta,” says Harvey.\nCheaper valuations mean less potential downside in a market correction. And, contrary to much of the rest of the stock market, higher interest rates would be a tailwind for the banks, which could then charge more for loans.\nHealthcare stocks also have some fans. “Healthcare has both defensive and growth attributes to it,” Wilson says. “You’re paying a lot less per unit of growth in healthcare today than you are in other sectors. So we think it provides good balance in this market when we’re worried about valuation.” Health insurerHumana(HUM) makes Wilson’s “Fresh Money Buy List” of stocks Buy-rated by Morgan Stanley analysts and fitting his macro views.\nNuveen’s Malik is also looking toward health care for relatively underpriced growth exposure, namely in the pharmaceuticals and biotechnology groups. She points toSeagen(SGEN), which is focused on oncology drugs and could be an attractive acquisition target for a pharma giant.\nMalik also likesAbbVie(ABBV) which trades at an undemanding eight times forward earnings and sports a 4.7% dividend yield. The coming expiration of patents on its blockbuster anti-inflammatory drug Humira has kept some investors away, but Malik is confident that management can limit the damage and sees promising drugs in development at the $200 billion company.\nBoth stocks have had a tough time in recent days. Seagen fell more than 8% last week, to around $152, on news that its co-founder and CEO sold a large number of shares recently. AndAbbVietanked 7% Wednesday, to $112.27, after the Food and Drug Administration required new warning labels for JAK inhibitors, a type of anti-rheumatoid drug that includes one of AbbVie’s most promising post-Humira products.\nPfizer(PFE),American Express(AXP),Johnson & Johnson(JNJ), andCisco Systems(CSCO) are other S&P 500 members that pass aBarron’sscreen for quality attributes.\nAfter a year of steady gains, investors might be reminded this fall that stocks can also decline, as growth momentum and policy support begin to fade. But underlying economic strength supports buying the dip, should the market drop from its highs. Just be more selective. And go with quality.","news_type":1},"isVote":1,"tweetType":1,"viewCount":837,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815272793,"gmtCreate":1630684150912,"gmtModify":1676530377095,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815272793","repostId":"1196145266","repostType":4,"isVote":1,"tweetType":1,"viewCount":691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818425572,"gmtCreate":1630430606796,"gmtModify":1676530302054,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818425572","repostId":"1166102613","repostType":4,"isVote":1,"tweetType":1,"viewCount":1162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813894611,"gmtCreate":1630164774233,"gmtModify":1676530237106,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/813894611","repostId":"2162733980","repostType":4,"repost":{"id":"2162733980","kind":"news","pubTimestamp":1630112394,"share":"https://ttm.financial/m/news/2162733980?lang=&edition=full_marsco","pubTime":"2021-08-28 08:59","market":"us","language":"en","title":"Morgan Stanley Bought $240M Shares Of Grayscale Bitcoin Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2162733980","media":"Benzinga","summary":"What Happened: Investment banking giant Morgan Stanley (NYSE: MS) is now the second-largest sharehol","content":"<p><b>What Happened: </b>Investment banking giant <b><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> </b>(NYSE: MS) is now the second-largest shareholder of the <b>Grayscale Bitcoin Trust </b>(OTCMKTS:&nbsp;GBTC) after ARK Investment Management.</p>\n<p>According to recent SEC filings, Morgan Stanley owns over 6.5 million shares of GBTC worth over $240 million at the time of writing.</p>\n<p>Cathie Wood’s ARK Invest funds currently own 9 million shares worth $350 million.</p>\n<p>Morgan Stanley’s GBTC holdings are spread out across a series of funds, of which the Morgan Stanley Insight Fund holds close to 1 million shares.</p>\n<p>The purchases over the past few months also demonstrate how significantly Morgan Stanley has increased its exposure to the leading digital asset.</p>\n<p>At the end of June, the firm reported holding 28,000 shares of GBTC worth around $800,000 at the time.</p>\n<p><b>What Else:</b> The Grayscale Bitcoin Trust itself holds over $31.24 billion of <b>Bitcoin </b>(CRYPTO: BTC) according to a recent update of its assets under management.</p>\n<p>The digital asset management firm had an overall AUM of over $43 billion at the time of writing, of which nearly $10 billion is held in the <b>Grayscale Ethereum Trust </b>(OTCMKTS:&nbsp;ETHE).</p>\n<p>Earlier this year, Grayscale revealed that it was 100% committed to converting its Bitcoin trust, which is currently the largest in the world, into an Exchange Traded Fund (ETF).</p>\n<p><b>Price Action:</b> At press time, GBTC shares was trading $39.15, up 3.52%. Bitcoin was up 3.66% over the past 24-hours, trading at a price of $48,976.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Bought $240M Shares Of Grayscale Bitcoin Trust</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Bought $240M Shares Of Grayscale Bitcoin Trust\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-28 08:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/morgan-stanley-bought-240m-shares-211654020.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What Happened: Investment banking giant Morgan Stanley (NYSE: MS) is now the second-largest shareholder of the Grayscale Bitcoin Trust (OTCMKTS: GBTC) after ARK Investment Management.\nAccording to ...</p>\n\n<a href=\"https://finance.yahoo.com/news/morgan-stanley-bought-240m-shares-211654020.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MS":"摩根士丹利"},"source_url":"https://finance.yahoo.com/news/morgan-stanley-bought-240m-shares-211654020.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162733980","content_text":"What Happened: Investment banking giant Morgan Stanley (NYSE: MS) is now the second-largest shareholder of the Grayscale Bitcoin Trust (OTCMKTS: GBTC) after ARK Investment Management.\nAccording to recent SEC filings, Morgan Stanley owns over 6.5 million shares of GBTC worth over $240 million at the time of writing.\nCathie Wood’s ARK Invest funds currently own 9 million shares worth $350 million.\nMorgan Stanley’s GBTC holdings are spread out across a series of funds, of which the Morgan Stanley Insight Fund holds close to 1 million shares.\nThe purchases over the past few months also demonstrate how significantly Morgan Stanley has increased its exposure to the leading digital asset.\nAt the end of June, the firm reported holding 28,000 shares of GBTC worth around $800,000 at the time.\nWhat Else: The Grayscale Bitcoin Trust itself holds over $31.24 billion of Bitcoin (CRYPTO: BTC) according to a recent update of its assets under management.\nThe digital asset management firm had an overall AUM of over $43 billion at the time of writing, of which nearly $10 billion is held in the Grayscale Ethereum Trust (OTCMKTS: ETHE).\nEarlier this year, Grayscale revealed that it was 100% committed to converting its Bitcoin trust, which is currently the largest in the world, into an Exchange Traded Fund (ETF).\nPrice Action: At press time, GBTC shares was trading $39.15, up 3.52%. Bitcoin was up 3.66% over the past 24-hours, trading at a price of $48,976.","news_type":1},"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810486708,"gmtCreate":1629992573004,"gmtModify":1676530196155,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like please? Thanks!&nbsp;","listText":"Like please? Thanks!&nbsp;","text":"Like please? Thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/810486708","repostId":"2162931260","repostType":4,"repost":{"id":"2162931260","kind":"highlight","pubTimestamp":1629982994,"share":"https://ttm.financial/m/news/2162931260?lang=&edition=full_marsco","pubTime":"2021-08-26 21:03","market":"us","language":"en","title":"4 Growth Stocks With 116% to 247% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2162931260","media":"Motley Fool","summary":"Analysts' high-water price targets foresee these fast-growing stocks doubling or tripling in value.","content":"<p>Patience has paid off handsomely for investors in 2021. It's been over nine months since the benchmark <b>S&amp;P 500</b> underwent even a 5% correction. Panning out a bit further, the widely followed index has doubled since hitting its bear-market low on March 23, 2020.</p>\n<p>Yet, even with the stock market mowing down record highs on a regular basis this year, Wall Street still sees value in a number of growth stocks. Based on the highest price target issued by a Wall Street analyst or investment bank, the following four growth stocks could deliver gains ranging from 116% to as much as 247%.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640299%2Fbull-market-rising-stock-chart-economy-bear-newspaper-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"525\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Tesla Motors: Implied upside of 134%</h2>\n<p>Few stocks are as polarizing on Wall Street, from the perspective of price targets, than electric vehicle (EV) company <b>Tesla Motors</b> (NASDAQ:TSLA). Whereas <a href=\"https://laohu8.com/S/AONE.U\">one</a> analyst foresees approximately 90% downside in shares of the company, another believes Tesla could \"motor\" its way to $1,591 a share. This would represent 134% upside from where the company ended this past week.</p>\n<p>On one hand, Tesla has clear-cut advantages that are driving it forward. For instance, its battery technology offers more capacity, range, and power than competing EV manufacturers. Tesla has also built itself from the ground up to mass production. Based on its second-quarter deliveries of 201,250, the company looks to be on its way to topping 1 million annual deliveries by as soon as next year.&nbsp; Finally, don't overlook that Tesla has visionary Elon Musk as its CEO.</p>\n<p>On the other hand, it's unlikely that Tesla will be able to hang onto its competitive edges over the long run, with auto stocks like <b>Ford Motor Company</b>&nbsp;and <b>General Motors</b>&nbsp;respectively investing $30 billion and $35 billion through mid-decade in EVs and related technology. Both companies plan to respectively launch 30 new EVs globally by 2025.</p>\n<p>Perhaps the biggest concern is that Tesla hadn't generated a true operating profit until the latest quarter. Though it's been profitable for more than a year, the company had relied on selling renewable energy credits and one-time asset sales (e.g., <b>Bitcoin</b>) to generate a profit. If Tesla is ever going to hit $1,591 a share, its EV sales, not one-time benefits, will have to do the talking.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640299%2Fmarijuana-cannabis-oil-pot-weed-leaf-drug-medical-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"568\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Green Thumb Industries: Implied upside of 116%</h2>\n<p>Wall Street also sees U.S. marijuana stocks budding over the coming year. In particular, one Wall Street analyst believes multistate operator (MSO) <b>Green Thumb Industries</b> (OTC:GTBIF) can rally to north of $61 a share, which would equate to 116% implied upside.</p>\n<p>The great thing for U.S. MSOs is that they don't need federal reform to thrive. We've watched 36 states legalize cannabis in some capacity, which is providing more than enough of a growth opportunity for MSOs and ancillary players to succeed. By mid-decade, <a href=\"https://laohu8.com/S/NFC.U\">New Frontier</a> Data is predicting that the U.S. weed industry could bring in $41.5 billion in annual sales.</p>\n<p>Green Thumb currently has 62 operating dispensaries, with 111 total retail licenses in its back pocket and a presence in 14 states. This is a company that's been picky about its expansion and has generally focused on either high-dollar states or markets protected by limited license issuance. In Illinois, for instance, the number of retail licenses issued, in total and to a single business, is capped. This should give Green Thumb a good opportunity to gobble up market share in a billion-dollar market.</p>\n<p>But the best aspect of Green Thumb is arguably its product mix. A majority of the company's sales come from derivatives, such as vapes, edibles, and infused beverages. Since derivatives generate higher margins than dried cannabis flower and are less likely to face supply issues, they're the reason Green Thumb has been profitable on a recurring basis for the past year. In other words, Wall Street's most aggressive price target may become a reality.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/69c8d46ab082fe9b933b958f3354a003\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Skillz: Implied upside of 138%</h2>\n<p>Another high-growth stock at least one Wall Street analyst believes could soar is mobile gaming platform <b>Skillz</b> (NYSE:SKLZ). With a high-water price target of $25, the implication is that Skillz could return up to 138% for its shareholders over the next year.</p>\n<p>To be upfront, Skillz has performed very poorly of late. It's lost more than three-quarters of its value since early February, which is a reflection of the company's operating losses expanding. Skillz has been increasing its headcount, marketing to expand its reach, and making acquisitions. This all points to ongoing operating losses for the foreseeable future.</p>\n<p>However, there's no denying the potential for this company, either. During the first quarter, approximately 17% of its monthly active users were paying to play on its platform, which is substantially higher than the industry conversion average of around 2%. Furthermore, with Skillz acting as a middleman platform for gamers, its ongoing operating expenses (aside from marketing) are quite low. As a result, it's been consistently generating a gross margin of 95%.</p>\n<p>Probably the most exciting thing for Skillz is the multiyear agreement it signed with the National Football League (NFL) in February. Football is the most popular sport in the United States. The expectation is that NFL-themed games will hit its platform in 2022, which could bring in a number of new users and partnerships.</p>\n<p>While I do believe a $25 price target is possible, investors will need to exercise patience as Skillz focuses on expanding its brand.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640299%2Fbiotech-lab-researcher-examining-test-tube-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Exelixis: Implied upside of 247%</h2>\n<p>But the crème de la crème of potential upside comes from biotech stock <b>Exelixis</b> (NASDAQ:EXEL). With investment firm HC Wainwright recently anointing Exelixis with a $64 price target, the implied upside for shareholders is an insane 247%, based on where it closed last week. In fact, Exelixis' share price is currently below all 13 issued Wall Street price targets.</p>\n<p>If you're looking for a reason behind Exelixis' relative \"cheapness\" to Wall Street's price targets, the company's late-June interim data release from the Cosmic-312 study holds the answer. While the ongoing phase 3 study of Exelixis' leading cancer drug, Cabometyx, in combination with atezolizumab demonstrated a statistically significant improvement in progression-free survival for previously untreated liver cancer patients, the data looked unlikely to produce a statistically significant survival benefit.</p>\n<p>Although this might sound like a disappointment, it's par for the course when developing cancer drugs. Thus far, Cabometyx has been approved as a treatment for first- and second-line renal cell carcinoma (RCC) and advanced hepatocellular carcinoma. These indications alone should push its annual sales past $1 billion in 2022.</p>\n<p>However, Cabometyx is being examined in around six dozen additional studies as a monotherapy or combination treatment. If even a handful of these trials succeed, label expansion opportunities could send Exelixis markedly higher. It's worth pointing out that one of these studies, CheckMate-9ER, already led the Food and Drug Administration to approve the combination of Cabometyx and <b>Bristol Myers Squibb</b>'s cancer immunotherapy Opdivo as a treatment for first-line RCC.</p>\n<p>With a hearty cash pile and plenty of long-term momentum for Cabometyx, Exelixis looks incredibly cheap. I'm not certain that $64 is in the cards, but higher than where it currently sits is the direction it's likely headed.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Growth Stocks With 116% to 247% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Growth Stocks With 116% to 247% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 21:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/26/4-growth-stocks-with-116-to-247-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Patience has paid off handsomely for investors in 2021. It's been over nine months since the benchmark S&P 500 underwent even a 5% correction. Panning out a bit further, the widely followed index has ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/26/4-growth-stocks-with-116-to-247-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SKLZ":"Skillz Inc","GTBIF":"Green Thumb Industries Inc.","TSLA":"特斯拉","EXEL":"伊克力西斯"},"source_url":"https://www.fool.com/investing/2021/08/26/4-growth-stocks-with-116-to-247-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162931260","content_text":"Patience has paid off handsomely for investors in 2021. It's been over nine months since the benchmark S&P 500 underwent even a 5% correction. Panning out a bit further, the widely followed index has doubled since hitting its bear-market low on March 23, 2020.\nYet, even with the stock market mowing down record highs on a regular basis this year, Wall Street still sees value in a number of growth stocks. Based on the highest price target issued by a Wall Street analyst or investment bank, the following four growth stocks could deliver gains ranging from 116% to as much as 247%.\nImage source: Getty Images.\nTesla Motors: Implied upside of 134%\nFew stocks are as polarizing on Wall Street, from the perspective of price targets, than electric vehicle (EV) company Tesla Motors (NASDAQ:TSLA). Whereas one analyst foresees approximately 90% downside in shares of the company, another believes Tesla could \"motor\" its way to $1,591 a share. This would represent 134% upside from where the company ended this past week.\nOn one hand, Tesla has clear-cut advantages that are driving it forward. For instance, its battery technology offers more capacity, range, and power than competing EV manufacturers. Tesla has also built itself from the ground up to mass production. Based on its second-quarter deliveries of 201,250, the company looks to be on its way to topping 1 million annual deliveries by as soon as next year.  Finally, don't overlook that Tesla has visionary Elon Musk as its CEO.\nOn the other hand, it's unlikely that Tesla will be able to hang onto its competitive edges over the long run, with auto stocks like Ford Motor Company and General Motors respectively investing $30 billion and $35 billion through mid-decade in EVs and related technology. Both companies plan to respectively launch 30 new EVs globally by 2025.\nPerhaps the biggest concern is that Tesla hadn't generated a true operating profit until the latest quarter. Though it's been profitable for more than a year, the company had relied on selling renewable energy credits and one-time asset sales (e.g., Bitcoin) to generate a profit. If Tesla is ever going to hit $1,591 a share, its EV sales, not one-time benefits, will have to do the talking.\nImage source: Getty Images.\nGreen Thumb Industries: Implied upside of 116%\nWall Street also sees U.S. marijuana stocks budding over the coming year. In particular, one Wall Street analyst believes multistate operator (MSO) Green Thumb Industries (OTC:GTBIF) can rally to north of $61 a share, which would equate to 116% implied upside.\nThe great thing for U.S. MSOs is that they don't need federal reform to thrive. We've watched 36 states legalize cannabis in some capacity, which is providing more than enough of a growth opportunity for MSOs and ancillary players to succeed. By mid-decade, New Frontier Data is predicting that the U.S. weed industry could bring in $41.5 billion in annual sales.\nGreen Thumb currently has 62 operating dispensaries, with 111 total retail licenses in its back pocket and a presence in 14 states. This is a company that's been picky about its expansion and has generally focused on either high-dollar states or markets protected by limited license issuance. In Illinois, for instance, the number of retail licenses issued, in total and to a single business, is capped. This should give Green Thumb a good opportunity to gobble up market share in a billion-dollar market.\nBut the best aspect of Green Thumb is arguably its product mix. A majority of the company's sales come from derivatives, such as vapes, edibles, and infused beverages. Since derivatives generate higher margins than dried cannabis flower and are less likely to face supply issues, they're the reason Green Thumb has been profitable on a recurring basis for the past year. In other words, Wall Street's most aggressive price target may become a reality.\nImage source: Getty Images.\nSkillz: Implied upside of 138%\nAnother high-growth stock at least one Wall Street analyst believes could soar is mobile gaming platform Skillz (NYSE:SKLZ). With a high-water price target of $25, the implication is that Skillz could return up to 138% for its shareholders over the next year.\nTo be upfront, Skillz has performed very poorly of late. It's lost more than three-quarters of its value since early February, which is a reflection of the company's operating losses expanding. Skillz has been increasing its headcount, marketing to expand its reach, and making acquisitions. This all points to ongoing operating losses for the foreseeable future.\nHowever, there's no denying the potential for this company, either. During the first quarter, approximately 17% of its monthly active users were paying to play on its platform, which is substantially higher than the industry conversion average of around 2%. Furthermore, with Skillz acting as a middleman platform for gamers, its ongoing operating expenses (aside from marketing) are quite low. As a result, it's been consistently generating a gross margin of 95%.\nProbably the most exciting thing for Skillz is the multiyear agreement it signed with the National Football League (NFL) in February. Football is the most popular sport in the United States. The expectation is that NFL-themed games will hit its platform in 2022, which could bring in a number of new users and partnerships.\nWhile I do believe a $25 price target is possible, investors will need to exercise patience as Skillz focuses on expanding its brand.\nImage source: Getty Images.\nExelixis: Implied upside of 247%\nBut the crème de la crème of potential upside comes from biotech stock Exelixis (NASDAQ:EXEL). With investment firm HC Wainwright recently anointing Exelixis with a $64 price target, the implied upside for shareholders is an insane 247%, based on where it closed last week. In fact, Exelixis' share price is currently below all 13 issued Wall Street price targets.\nIf you're looking for a reason behind Exelixis' relative \"cheapness\" to Wall Street's price targets, the company's late-June interim data release from the Cosmic-312 study holds the answer. While the ongoing phase 3 study of Exelixis' leading cancer drug, Cabometyx, in combination with atezolizumab demonstrated a statistically significant improvement in progression-free survival for previously untreated liver cancer patients, the data looked unlikely to produce a statistically significant survival benefit.\nAlthough this might sound like a disappointment, it's par for the course when developing cancer drugs. Thus far, Cabometyx has been approved as a treatment for first- and second-line renal cell carcinoma (RCC) and advanced hepatocellular carcinoma. These indications alone should push its annual sales past $1 billion in 2022.\nHowever, Cabometyx is being examined in around six dozen additional studies as a monotherapy or combination treatment. If even a handful of these trials succeed, label expansion opportunities could send Exelixis markedly higher. It's worth pointing out that one of these studies, CheckMate-9ER, already led the Food and Drug Administration to approve the combination of Cabometyx and Bristol Myers Squibb's cancer immunotherapy Opdivo as a treatment for first-line RCC.\nWith a hearty cash pile and plenty of long-term momentum for Cabometyx, Exelixis looks incredibly cheap. I'm not certain that $64 is in the cards, but higher than where it currently sits is the direction it's likely headed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835471782,"gmtCreate":1629736441546,"gmtModify":1676530117342,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Please shoot up!","listText":"Please shoot up!","text":"Please shoot up!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835471782","repostId":"1179203616","repostType":4,"repost":{"id":"1179203616","kind":"news","pubTimestamp":1629732335,"share":"https://ttm.financial/m/news/1179203616?lang=&edition=full_marsco","pubTime":"2021-08-23 23:25","market":"us","language":"en","title":"Palantir Is an Enigma. The Opportunity in Its Stock Is Far More Clear.","url":"https://stock-news.laohu8.com/highlight/detail?id=1179203616","media":"Barrons","summary":"Palantir Technologies is one of the world’s quirkiest tech companies, and last week the story got we","content":"<p>Palantir Technologies is one of the world’s quirkiest tech companies, and last week the story got weirder than ever. But beneath the surface, there’s an oddly compelling case for the business and the stock.</p>\n<p>Palantir (ticker: PLTR) provides data analytics software to both commercial and government clients. The 18-year-old company has two primary platforms—Gotham, for government applications, and Foundry, for commercial customers. Palantir has a long history of serving U.S. military and intelligence agencies, but lately it’s&nbsp;been building out its sales team to bulk up its commercial business. That plan seems to be getting traction.</p>\n<p>Palantir went public in a direct listing last September, with the stock&nbsp;opening at $10. It’s since taken shareholders on a wild ride, trading as high as $45 earlier this year. It’s now around $25, still up 150% from listing day.</p>\n<p>In its&nbsp;recently reported June quarter, Palantir posted revenue of $376 million, up 49% from the year-earlier level. The company got a big boost from its U.S. commercial business, which grew 90%. Palantir sees September quarter revenue inching up to $385 million, and it continues to forecast annual top-line growth of 30%-plus through 2025.</p>\n<p>But the core story gets lost in the noise—Palantir seems to thrive on controversy. Almost everything it does is outside the box. Before last year’s stock listing, Palantir quietly moved its headquarters to Denver from Palo Alto. The reasoning boils down to politics.</p>\n<p>“When we started the company in 2004, the idea was to bring world-class software to our intelligence and military communities,” Palantir CEO Alex Karp&nbsp;told me in a June interview. “Numerous companies in Silicon Valley have refused either overtly, tacitly, or by dragging their feet, to work with the U.S. government. … I believe in general there’s a choice to be made in the world, and America has serious, rigorous, intelligent, and sometimes ruthless adversaries.”</p>\n<p>Palantir has also been doing unusual things with the $2.4 billion in cash on its balance sheet. The company is&nbsp;aggressively investing in PIPEs, or private investments in public equities, which are used in almost every SPAC merger to increase the capital raised. Palantir has&nbsp;committed $310 million across more than a dozen SPACs, or special purpose acquisition companies, according to its latest SEC filing. It’s completed $33 million of equity investments across three other companies.</p>\n<p></p>\n<p>The most recent tranche includes $20 million for Fast Radius, which offers a “cloud manufacturing platform;” $15 million for Tritium, a developer of electric vehicle chargers; $15 million for AdTheorent, which sells advertising software driven by machine learning; and $10 million for FinAccel, an Asian financial-services company.</p>\n<p>All the targets have signed up to be Palantir customers. As of June 30, Palantir said it had commercial contracts with its SPAC portfolio companies with a potential value of $428 million; the revenue contribution in the latest quarter was just $3 million, or less than 1% of the total.</p>\n<p>SPACs are a highly speculative place for a public company to be parking its cash. But I’d argue that Palantir’s decision to provide capital to new customers isn’t so different from offering vendor debt financing for hardware purchases—as&nbsp;IBM(IBM) and HP Enterprise (HPE) do—or from running robust venture capital programs, as do&nbsp;Intel(INTC) and&nbsp;Salesforce.com(CRM).</p>\n<p>Even so, it makes some analysts squeamish. “While we don’t oppose thinking outside the box, we think the strategy may have been taken too far, particularly with software contracts that appear to be negotiated alongside an investment by Palantir in the same customer,” Citi’s Tyler Radke wrote in a recent research note.</p>\n<p>The outside-the-box strategy goes beyond SPACs. This past week, Palantir disclosed that it had purchased $50.7 million worth of 100-ounce gold bars—a pretty strange move, even for Palantir. I ran a text search in the SEC’s database looking for references to gold bars, and found only references to other gold companies. The move makes&nbsp;Tesla’s(TSLA) Bitcoin purchases seem mundane.</p>\n<p>The fact that Palantir decided to buy physical gold, rather than, say, the&nbsp;SPDR Gold Shares&nbsp;ETF (GLD), makes it odder still. Palatnir ends up looking like the corporate equivalent of a doomsday prepper. I tried to follow-up with Karp to ask about the sudden interest in gold, but Palantir declined to make him available.</p>\n<p>One analyst who follows the company told me that the SPAC program and the foray into gold make Palantir a hard sell for institutional investors. You can see that in the shareholder base. Institutions hold only 25% of Palantir shares—compared with&nbsp;Oracle’s(ORCL) 46%,Snowflake’s(SNOW) 58%, and&nbsp;Microsoft’s(MSFT) 71%.</p>\n<p>But the same analyst is still bullish on Palantir and says it offers “a very interesting set of solutions to buyers that require scale and sophistication.”</p>\n<p>Palantir has a fanatical following among individual investors, and the company is playing to its fans. During its June-quarter earnings call, Palantir took nine questions from retail investors and just four from analysts.</p>\n<p>On traditional metrics, Palantir isn’t cheap. The stock trades for 25 times estimated 2022 sales. But strip away the craziness, and Palantir looks like the single best bet on the future of complex data analytics. There aren’t many other ways for investors to play the opportunity—and the world isn’t getting any simpler or less dangerous.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Is an Enigma. The Opportunity in Its Stock Is Far More Clear.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Is an Enigma. The Opportunity in Its Stock Is Far More Clear.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/palantir-stock-spacs-gold-51629497963?mod=hp_LEADSUPP_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies is one of the world’s quirkiest tech companies, and last week the story got weirder than ever. But beneath the surface, there’s an oddly compelling case for the business and the ...</p>\n\n<a href=\"https://www.barrons.com/articles/palantir-stock-spacs-gold-51629497963?mod=hp_LEADSUPP_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.barrons.com/articles/palantir-stock-spacs-gold-51629497963?mod=hp_LEADSUPP_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179203616","content_text":"Palantir Technologies is one of the world’s quirkiest tech companies, and last week the story got weirder than ever. But beneath the surface, there’s an oddly compelling case for the business and the stock.\nPalantir (ticker: PLTR) provides data analytics software to both commercial and government clients. The 18-year-old company has two primary platforms—Gotham, for government applications, and Foundry, for commercial customers. Palantir has a long history of serving U.S. military and intelligence agencies, but lately it’s been building out its sales team to bulk up its commercial business. That plan seems to be getting traction.\nPalantir went public in a direct listing last September, with the stock opening at $10. It’s since taken shareholders on a wild ride, trading as high as $45 earlier this year. It’s now around $25, still up 150% from listing day.\nIn its recently reported June quarter, Palantir posted revenue of $376 million, up 49% from the year-earlier level. The company got a big boost from its U.S. commercial business, which grew 90%. Palantir sees September quarter revenue inching up to $385 million, and it continues to forecast annual top-line growth of 30%-plus through 2025.\nBut the core story gets lost in the noise—Palantir seems to thrive on controversy. Almost everything it does is outside the box. Before last year’s stock listing, Palantir quietly moved its headquarters to Denver from Palo Alto. The reasoning boils down to politics.\n“When we started the company in 2004, the idea was to bring world-class software to our intelligence and military communities,” Palantir CEO Alex Karp told me in a June interview. “Numerous companies in Silicon Valley have refused either overtly, tacitly, or by dragging their feet, to work with the U.S. government. … I believe in general there’s a choice to be made in the world, and America has serious, rigorous, intelligent, and sometimes ruthless adversaries.”\nPalantir has also been doing unusual things with the $2.4 billion in cash on its balance sheet. The company is aggressively investing in PIPEs, or private investments in public equities, which are used in almost every SPAC merger to increase the capital raised. Palantir has committed $310 million across more than a dozen SPACs, or special purpose acquisition companies, according to its latest SEC filing. It’s completed $33 million of equity investments across three other companies.\n\nThe most recent tranche includes $20 million for Fast Radius, which offers a “cloud manufacturing platform;” $15 million for Tritium, a developer of electric vehicle chargers; $15 million for AdTheorent, which sells advertising software driven by machine learning; and $10 million for FinAccel, an Asian financial-services company.\nAll the targets have signed up to be Palantir customers. As of June 30, Palantir said it had commercial contracts with its SPAC portfolio companies with a potential value of $428 million; the revenue contribution in the latest quarter was just $3 million, or less than 1% of the total.\nSPACs are a highly speculative place for a public company to be parking its cash. But I’d argue that Palantir’s decision to provide capital to new customers isn’t so different from offering vendor debt financing for hardware purchases—as IBM(IBM) and HP Enterprise (HPE) do—or from running robust venture capital programs, as do Intel(INTC) and Salesforce.com(CRM).\nEven so, it makes some analysts squeamish. “While we don’t oppose thinking outside the box, we think the strategy may have been taken too far, particularly with software contracts that appear to be negotiated alongside an investment by Palantir in the same customer,” Citi’s Tyler Radke wrote in a recent research note.\nThe outside-the-box strategy goes beyond SPACs. This past week, Palantir disclosed that it had purchased $50.7 million worth of 100-ounce gold bars—a pretty strange move, even for Palantir. I ran a text search in the SEC’s database looking for references to gold bars, and found only references to other gold companies. The move makes Tesla’s(TSLA) Bitcoin purchases seem mundane.\nThe fact that Palantir decided to buy physical gold, rather than, say, the SPDR Gold Shares ETF (GLD), makes it odder still. Palatnir ends up looking like the corporate equivalent of a doomsday prepper. I tried to follow-up with Karp to ask about the sudden interest in gold, but Palantir declined to make him available.\nOne analyst who follows the company told me that the SPAC program and the foray into gold make Palantir a hard sell for institutional investors. You can see that in the shareholder base. Institutions hold only 25% of Palantir shares—compared with Oracle’s(ORCL) 46%,Snowflake’s(SNOW) 58%, and Microsoft’s(MSFT) 71%.\nBut the same analyst is still bullish on Palantir and says it offers “a very interesting set of solutions to buyers that require scale and sophistication.”\nPalantir has a fanatical following among individual investors, and the company is playing to its fans. During its June-quarter earnings call, Palantir took nine questions from retail investors and just four from analysts.\nOn traditional metrics, Palantir isn’t cheap. The stock trades for 25 times estimated 2022 sales. But strip away the craziness, and Palantir looks like the single best bet on the future of complex data analytics. There aren’t many other ways for investors to play the opportunity—and the world isn’t getting any simpler or less dangerous.","news_type":1},"isVote":1,"tweetType":1,"viewCount":385,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835473225,"gmtCreate":1629736373367,"gmtModify":1676530117244,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Ok, pls like!","listText":"Ok, pls like!","text":"Ok, pls like!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835473225","repostId":"2161747692","repostType":4,"repost":{"id":"2161747692","kind":"news","pubTimestamp":1629673828,"share":"https://ttm.financial/m/news/2161747692?lang=&edition=full_marsco","pubTime":"2021-08-23 07:10","market":"us","language":"en","title":"Fed's Jackson Hole Symposium, personal income and spending: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2161747692","media":"Yahoo Finance","summary":"Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at","content":"<p>Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at the bank's annual Jackson Hole Economic Policy Symposium.</p>\n<p>The event, which takes place from Thursday to Saturday this week, is set to serve as a forum for more discussions around Fed policymakers' plans to announce and implement a shift in the central bank's monetary policy stance. Namely, investors have been closely watching for months to hear when officials will begin tapering their purchases of Treasury and mortgage securities, which have been taking place at a pace of $120 billion per month for more than a year during the pandemic.</p>\n<p>This asset purchase program had been a major policy underpinning U.S. equity markets this year, providing liquidity throughout the economic crisis induced by the virus. But as the economy makes headway in recovering, Fed officials' talk around pulling in the reins on this program has started to increase.</p>\n<p>Last week, Federal Reserve officials signaled the announcement of the start of tapering was edging closer. According to the meeting minutes from the Federal Reserve's July meeting, most monetary policymakers believed the economy will have made enough progress toward recovering to warrant tapering.</p>\n<p>\"Most participants noted that, provided that the economy were to evolve broadly as they anticipated, they judged that it could be appropriate to start reducing the pace of asset purchases this year because they saw the Committee’s 'substantial further progress' criterion as satisfied with respect to the price-stability goal and as close to being satisfied with respect to the maximum employment goal,\" according to the FOMC minutes.</p>\n<p>But as many pundits have noted, the central bank still has a host of meetings left in 2021 to serve as a platform for further discussing or announcing tapering. As a result, Jackson Hole this week may cause few ripples, with policymakers like Federal Reserve Chair Jerome Powell sticking to their previously telegraphed language about waiting to see further improvements in the labor market before escalating talk of tapering further.</p>\n<p>\"Jackson Hole next week is certainly a target for when we might hear some actual firm language around taper. I'm not really expecting much out of Jackson Hole,\" Garrett Melson, Natixis Investment Managers Solutions portfolio strategist, told Yahoo Finance last week. \"We're more in the camp that we probably start to hear something around the November meeting. Perhaps they're as quick as December to start actually implementing the taper. But I'm still more in the camp that January is probably when we begin to see a slow taper, probably in the ballpark of $15 billion per month.\"</p>\n<p>\"They're still very, very dovish. They're slightly less dovish,\" he added. \"But that's a little semantics at this point. Taper is very well documented and well known. We know it's coming. It's just a matter of timing and really shouldn't surprise many investors out there.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ffd135dd0d8cdc399e0982d54e39f5bd\" tg-width=\"6000\" tg-height=\"4000\" width=\"100%\" height=\"auto\"><span>Federal Reserve Board Chair Jerome Powell testifies before Senate Banking, Housing, and Urban Affairs hearing to examine the Semiannual Monetary Policy Report to Congress, July 15, 2021, on Capitol Hill. (AP Photo/Jose Luis Magana, file)ASSOCIATED PRESS</span></p>\n<p>As for the ultimate market impact of tapering, if the outcome is anything like the response from the last announcement of tapering in 2023, investors might brace for a momentary bout of volatility and some sector rotation beneath the surface.</p>\n<p>\"In 2013, Fed Chair Bernanke's comments about tapering catalyzed a five-day, 40 bp backup in 10-year yields and a 5% drop in the S&amp;P 500,\" said David Kostin, Goldman Sachs' chief U.S. equity strategist, in a note last week. \"The initial signal from the taper tantrum ultimately proved fleeting during a year with extremely strong returns for equities.\"</p>\n<p>\"The S&amp;P 500 rebounded 5% in the roughly two months following the tantrum, led higher by the materials, consumer discretionary, and health care sectors,\" he added. \"By December, the S&amp;P 500 had posted a full-year return of 32%. As the Fed reiterated its commitment to accommodative policy, growth outperformed value and cyclical stocks outperformed defensives.\"</p>\n<h2>Personal spending, income</h2>\n<p>New economic data on consumer spending and income will also be in focus later this week, with reports on both metrics due for release on Friday.</p>\n<p>Consensus economists expect to see personal spending slow to just a 0.4% monthly clip in July, decelerating from June's 1.0% increase.</p>\n<p>Just last week, the Commerce Department's data showed retail sales fell more than expected in July, dipping by 1.1%. The print pointed to more moderation in spending as the impact of stimulus checks earlier this year waned further, and lowered the bar for the Bureau of Economic Analysis' monthly personal spending data.</p>\n<p>Other data has also underscored the slowdown in consumer spending, especially given the recent spread of the Delta variant starting in the middle of summer.</p>\n<p>\"Although services spending started strong in July boosted by the holiday, our aggregated BAC credit and debit card data suggest services spending, particularly for travel and leisure, slowed down noticeably in the second half of the month, potentially due to rising Delta concerns,\" Bank of America economist Michelle Meyer wrote in a note Friday.</p>\n<p>Friday's consumer spending report will also come with data on personal income, which is also expected to have ticked up only slightly on a monthly basis. Economists look for a 0.1% increase in July, which would match the pace from the prior month.</p>\n<p>Even with the deceleration in income, however, the personal savings rate may have increased as an early round of child tax credit payments helped offset a slowing pace of income growth, some economists noted.</p>\n<p>\"The advance child tax credit payments delivered this month translated into a lower tax burden and therefore a 1% month-over-month boost to disposable income, consequently leading to a rise in the savings rate to 10.0% from 9.4% in June,\" Meyer predicted.</p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b>Chicago Fed National Activity Index, July (0.09 in June); <a href=\"https://laohu8.com/S/MRKT\">Markit</a> U.S. Manufacturing PMI, August preliminary (62.8 expected, 63.4 in July); Markit U.S. Services PMI, August preliminary (59.0 expected, 59.9 in July); Markit U.S. Composite PMI, August preliminary (59.9 in July); Existing home sales, month-on-month, July (-0.3% expected, 1.4% in June)</p></li>\n <li><p><b>Tuesday: </b>Richmond Fed Manufacturing Index, August (25 expected, 27 in July); New home sales, month-on-month, July (3.6% expected, -6.6% in June)</p></li>\n <li><p><b>Wednesday: </b>MBA Mortgage Applications, week ended August 20 (-3.9% during prior week); Durable goods orders, July preliminary (-0.2% expected, 0.9% in June); Non-defense capital goods orders excluding aircraft, July preliminary (0.5% expected, 0.7% in June); Non-defense capital goods shipments excluding aircraft, July preliminary (0.6% in June)</p></li>\n <li><p><b>Thursday: </b>Initial jobless claims, week ended August 21 (352,000 expected, 348,000 during prior week); Continuing claims, week ended August 14 (2.780 million expected, 2.820 million during prior week); GDP annualized quarter-over-quarter, Q2 second estimate (6.6% expected, 6.5% in prior print); Personal consumption, Q2 second estimate (12.3% expected, 11.8% in prior print); Core PCE quarter-over-quarter Q2 second estimate (6.1% expected, 6.1% in prior print); Kansas City Fed Manufacturing Activity Index, August (30 in prior print)</p></li>\n <li><p><b>Friday: </b>Advanced goods trade balance, July (-$90.9 billion expected, -$91.2 billion in June); Wholesale inventories, month-over-month, July preliminary (1.0% expected, 1.1% in June); Personal income, July (0.2% expected, 0.1% in June); Personal spending, July (0.4% expected, 1.0% in June); PCE core deflator, month-on-month, July (0.3% expected, 0.4% in June); PCE core deflator, year-on-year, July (3.6% expected, 3.5% in June); University of Michigan Sentiment, August final (71.0 expected, 70.2 in prior print)</p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday: </b>Advance Auto Parts (AAP) before market open; Intuit (INTU) after market close</p></li>\n <li><p><b>Wednesday: </b>Best Buy (BBY) before market open; <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> (CRM), Autodesk (ADSK), Ulta Beauty (ULTA) after market close</p></li>\n <li><p><b>Thursday: </b>The JM Smucker Co. (SJM), Dollar General (DG), Dollar Tree (DLTR) before market open; The Gap (GPS), HP Inc. (HPQ) after market close</p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release </i></p></li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed's Jackson Hole Symposium, personal income and spending: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed's Jackson Hole Symposium, personal income and spending: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 07:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/fed-heads-to-jackson-hole-personal-income-and-spending-what-to-know-this-week-150228513.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at the bank's annual Jackson Hole Economic Policy Symposium.\nThe event, which takes place from ...</p>\n\n<a href=\"https://finance.yahoo.com/news/fed-heads-to-jackson-hole-personal-income-and-spending-what-to-know-this-week-150228513.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WMT":"沃尔玛",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BBY":"百思买","XRT":"零售指数ETF-SPDR标普",".SPX":"S&P 500 Index","TGT":"塔吉特","SPY.AU":"SPDR® S&P 500® ETF Trust"},"source_url":"https://finance.yahoo.com/news/fed-heads-to-jackson-hole-personal-income-and-spending-what-to-know-this-week-150228513.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2161747692","content_text":"Traders this week are poised to focus closely on Federal Reserve policymakers' virtual appearance at the bank's annual Jackson Hole Economic Policy Symposium.\nThe event, which takes place from Thursday to Saturday this week, is set to serve as a forum for more discussions around Fed policymakers' plans to announce and implement a shift in the central bank's monetary policy stance. Namely, investors have been closely watching for months to hear when officials will begin tapering their purchases of Treasury and mortgage securities, which have been taking place at a pace of $120 billion per month for more than a year during the pandemic.\nThis asset purchase program had been a major policy underpinning U.S. equity markets this year, providing liquidity throughout the economic crisis induced by the virus. But as the economy makes headway in recovering, Fed officials' talk around pulling in the reins on this program has started to increase.\nLast week, Federal Reserve officials signaled the announcement of the start of tapering was edging closer. According to the meeting minutes from the Federal Reserve's July meeting, most monetary policymakers believed the economy will have made enough progress toward recovering to warrant tapering.\n\"Most participants noted that, provided that the economy were to evolve broadly as they anticipated, they judged that it could be appropriate to start reducing the pace of asset purchases this year because they saw the Committee’s 'substantial further progress' criterion as satisfied with respect to the price-stability goal and as close to being satisfied with respect to the maximum employment goal,\" according to the FOMC minutes.\nBut as many pundits have noted, the central bank still has a host of meetings left in 2021 to serve as a platform for further discussing or announcing tapering. As a result, Jackson Hole this week may cause few ripples, with policymakers like Federal Reserve Chair Jerome Powell sticking to their previously telegraphed language about waiting to see further improvements in the labor market before escalating talk of tapering further.\n\"Jackson Hole next week is certainly a target for when we might hear some actual firm language around taper. I'm not really expecting much out of Jackson Hole,\" Garrett Melson, Natixis Investment Managers Solutions portfolio strategist, told Yahoo Finance last week. \"We're more in the camp that we probably start to hear something around the November meeting. Perhaps they're as quick as December to start actually implementing the taper. But I'm still more in the camp that January is probably when we begin to see a slow taper, probably in the ballpark of $15 billion per month.\"\n\"They're still very, very dovish. They're slightly less dovish,\" he added. \"But that's a little semantics at this point. Taper is very well documented and well known. We know it's coming. It's just a matter of timing and really shouldn't surprise many investors out there.\"\nFederal Reserve Board Chair Jerome Powell testifies before Senate Banking, Housing, and Urban Affairs hearing to examine the Semiannual Monetary Policy Report to Congress, July 15, 2021, on Capitol Hill. (AP Photo/Jose Luis Magana, file)ASSOCIATED PRESS\nAs for the ultimate market impact of tapering, if the outcome is anything like the response from the last announcement of tapering in 2023, investors might brace for a momentary bout of volatility and some sector rotation beneath the surface.\n\"In 2013, Fed Chair Bernanke's comments about tapering catalyzed a five-day, 40 bp backup in 10-year yields and a 5% drop in the S&P 500,\" said David Kostin, Goldman Sachs' chief U.S. equity strategist, in a note last week. \"The initial signal from the taper tantrum ultimately proved fleeting during a year with extremely strong returns for equities.\"\n\"The S&P 500 rebounded 5% in the roughly two months following the tantrum, led higher by the materials, consumer discretionary, and health care sectors,\" he added. \"By December, the S&P 500 had posted a full-year return of 32%. As the Fed reiterated its commitment to accommodative policy, growth outperformed value and cyclical stocks outperformed defensives.\"\nPersonal spending, income\nNew economic data on consumer spending and income will also be in focus later this week, with reports on both metrics due for release on Friday.\nConsensus economists expect to see personal spending slow to just a 0.4% monthly clip in July, decelerating from June's 1.0% increase.\nJust last week, the Commerce Department's data showed retail sales fell more than expected in July, dipping by 1.1%. The print pointed to more moderation in spending as the impact of stimulus checks earlier this year waned further, and lowered the bar for the Bureau of Economic Analysis' monthly personal spending data.\nOther data has also underscored the slowdown in consumer spending, especially given the recent spread of the Delta variant starting in the middle of summer.\n\"Although services spending started strong in July boosted by the holiday, our aggregated BAC credit and debit card data suggest services spending, particularly for travel and leisure, slowed down noticeably in the second half of the month, potentially due to rising Delta concerns,\" Bank of America economist Michelle Meyer wrote in a note Friday.\nFriday's consumer spending report will also come with data on personal income, which is also expected to have ticked up only slightly on a monthly basis. Economists look for a 0.1% increase in July, which would match the pace from the prior month.\nEven with the deceleration in income, however, the personal savings rate may have increased as an early round of child tax credit payments helped offset a slowing pace of income growth, some economists noted.\n\"The advance child tax credit payments delivered this month translated into a lower tax burden and therefore a 1% month-over-month boost to disposable income, consequently leading to a rise in the savings rate to 10.0% from 9.4% in June,\" Meyer predicted.\nEconomic calendar\n\nMonday: Chicago Fed National Activity Index, July (0.09 in June); Markit U.S. Manufacturing PMI, August preliminary (62.8 expected, 63.4 in July); Markit U.S. Services PMI, August preliminary (59.0 expected, 59.9 in July); Markit U.S. Composite PMI, August preliminary (59.9 in July); Existing home sales, month-on-month, July (-0.3% expected, 1.4% in June)\nTuesday: Richmond Fed Manufacturing Index, August (25 expected, 27 in July); New home sales, month-on-month, July (3.6% expected, -6.6% in June)\nWednesday: MBA Mortgage Applications, week ended August 20 (-3.9% during prior week); Durable goods orders, July preliminary (-0.2% expected, 0.9% in June); Non-defense capital goods orders excluding aircraft, July preliminary (0.5% expected, 0.7% in June); Non-defense capital goods shipments excluding aircraft, July preliminary (0.6% in June)\nThursday: Initial jobless claims, week ended August 21 (352,000 expected, 348,000 during prior week); Continuing claims, week ended August 14 (2.780 million expected, 2.820 million during prior week); GDP annualized quarter-over-quarter, Q2 second estimate (6.6% expected, 6.5% in prior print); Personal consumption, Q2 second estimate (12.3% expected, 11.8% in prior print); Core PCE quarter-over-quarter Q2 second estimate (6.1% expected, 6.1% in prior print); Kansas City Fed Manufacturing Activity Index, August (30 in prior print)\nFriday: Advanced goods trade balance, July (-$90.9 billion expected, -$91.2 billion in June); Wholesale inventories, month-over-month, July preliminary (1.0% expected, 1.1% in June); Personal income, July (0.2% expected, 0.1% in June); Personal spending, July (0.4% expected, 1.0% in June); PCE core deflator, month-on-month, July (0.3% expected, 0.4% in June); PCE core deflator, year-on-year, July (3.6% expected, 3.5% in June); University of Michigan Sentiment, August final (71.0 expected, 70.2 in prior print)\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: Advance Auto Parts (AAP) before market open; Intuit (INTU) after market close\nWednesday: Best Buy (BBY) before market open; Salesforce (CRM), Autodesk (ADSK), Ulta Beauty (ULTA) after market close\nThursday: The JM Smucker Co. (SJM), Dollar General (DG), Dollar Tree (DLTR) before market open; The Gap (GPS), HP Inc. (HPQ) after market close\nFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832505823,"gmtCreate":1629647737662,"gmtModify":1676530085762,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/832505823","repostId":"1115632642","repostType":4,"isVote":1,"tweetType":1,"viewCount":518,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836699865,"gmtCreate":1629473325657,"gmtModify":1676530054166,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like please?&nbsp;","listText":"Like please?&nbsp;","text":"Like please?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/836699865","repostId":"2160710721","repostType":4,"repost":{"id":"2160710721","kind":"news","pubTimestamp":1629473265,"share":"https://ttm.financial/m/news/2160710721?lang=&edition=full_marsco","pubTime":"2021-08-20 23:27","market":"us","language":"en","title":"Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?","url":"https://stock-news.laohu8.com/highlight/detail?id=2160710721","media":"Zacks","summary":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. ","content":"<p><b>Moderna</b>’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a <a href=\"https://laohu8.com/S/WASH\">Washington</a> <a href=\"https://laohu8.com/S/POST\">Post</a> article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>/<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>’s mRNA-based vaccine, BNT162b.</p>\n<p>Per the same <a href=\"https://laohu8.com/S/WRE\">Washington</a> Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.</p>\n<p>We note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.</p>\n<p>Meanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.</p>\n<p>Shares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/01ae6084260e85bc39bcd6d72d8d9ae0\" tg-width=\"620\" tg-height=\"406\" referrerpolicy=\"no-referrer\"></p>\n<p>Image Source: Zacks Investment Research</p>\n<p>We note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with <b>J&amp;J</b>’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.</p>\n<p>Meanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination.&nbsp;The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).</p>\n<h3><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> Price</h3>\n<p><img src=\"https://static.tigerbbs.com/33512fafdd460236be3b7bc6e113462a\" tg-width=\"545\" tg-height=\"257\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> price | Moderna, Inc. Quote</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2160710721","content_text":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a Washington Post article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than Pfizer/BioNTech SE’s mRNA-based vaccine, BNT162b.\nPer the same Washington Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the United States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.\nWe note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.\nMeanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.\nShares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.\n\nImage Source: Zacks Investment Research\nWe note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with J&J’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.\nMeanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination. The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).\nModerna, Inc. Price\n\nModerna, Inc. price | Moderna, Inc. Quote","news_type":1},"isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830181010,"gmtCreate":1629029005430,"gmtModify":1676529913303,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/830181010","repostId":"1138531277","repostType":4,"isVote":1,"tweetType":1,"viewCount":544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895058891,"gmtCreate":1628696261213,"gmtModify":1676529825719,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Why wld they return the money... hmm pls like","listText":"Why wld they return the money... hmm pls like","text":"Why wld they return the money... hmm pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/895058891","repostId":"2158804152","repostType":4,"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892094041,"gmtCreate":1628609088683,"gmtModify":1676529797208,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/892094041","repostId":"1124291594","repostType":4,"isVote":1,"tweetType":1,"viewCount":303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891153902,"gmtCreate":1628353108406,"gmtModify":1703505357023,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582110607927501","idStr":"3582110607927501"},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/891153902","repostId":"1139912651","repostType":4,"isVote":1,"tweetType":1,"viewCount":634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":116391484,"gmtCreate":1622772793048,"gmtModify":1704190892823,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":8,"commentSize":11,"repostSize":0,"link":"https://ttm.financial/post/116391484","repostId":"1182667134","repostType":4,"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3569225668665653","authorId":"3569225668665653","name":"ZachLoh","avatar":"https://static.tigerbbs.com/39ae35b0a4b7e22dee7378b1bc1de2f6","crmLevel":8,"crmLevelSwitch":1,"idStr":"3569225668665653","authorIdStr":"3569225668665653"},"content":"Response bacK comment plz","text":"Response bacK comment plz","html":"Response bacK comment plz"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117565856,"gmtCreate":1623152144075,"gmtModify":1704197128653,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like and comment please, thank u. Will replyur post","listText":"Like and comment please, thank u. Will replyur post","text":"Like and comment please, thank u. Will replyur post","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/117565856","repostId":"1154765176","repostType":4,"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576141127250570","authorId":"3576141127250570","name":"Permapurps","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3576141127250570","authorIdStr":"3576141127250570"},"content":"Like and comment please","text":"Like and comment please","html":"Like and comment please"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116398358,"gmtCreate":1622772805974,"gmtModify":1704190893474,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/116398358","repostId":"1182667134","repostType":4,"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":192973519,"gmtCreate":1621140634731,"gmtModify":1704353309488,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Comment and like please, thank you","listText":"Comment and like please, thank you","text":"Comment and like please, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":8,"repostSize":0,"link":"https://ttm.financial/post/192973519","repostId":"1163454382","repostType":4,"isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3567160842587234","authorId":"3567160842587234","name":"Janicetxy","avatar":"https://static.tigerbbs.com/63b856bdd08debeda5ded66d11e6ed08","crmLevel":5,"crmLevelSwitch":0,"idStr":"3567160842587234","authorIdStr":"3567160842587234"},"content":"Pls help To reply to this comment thanks!","text":"Pls help To reply to this comment thanks!","html":"Pls help To reply to this comment thanks!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":104491191,"gmtCreate":1620401433813,"gmtModify":1704343258600,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Can someone respond to my comment?","listText":"Can someone respond to my comment?","text":"Can someone respond to my comment?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":9,"repostSize":0,"link":"https://ttm.financial/post/104491191","repostId":"1171540841","repostType":4,"isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3570769377369254","authorId":"3570769377369254","name":"Glenna","avatar":"https://static.tigerbbs.com/8cb1540811be40c4d05341502c35498c","crmLevel":2,"crmLevelSwitch":0,"idStr":"3570769377369254","authorIdStr":"3570769377369254"},"content":"ok pls do the same for me. thx ya","text":"ok pls do the same for me. thx ya","html":"ok pls do the same for me. thx ya"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137039374,"gmtCreate":1622266282698,"gmtModify":1704182527454,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Thankfully not another Ever Green! Like and comment pls, thanks","listText":"Thankfully not another Ever Green! Like and comment pls, thanks","text":"Thankfully not another Ever Green! Like and comment pls, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":8,"repostSize":0,"link":"https://ttm.financial/post/137039374","repostId":"2138488778","repostType":4,"isVote":1,"tweetType":1,"viewCount":219,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574200728285353","authorId":"3574200728285353","name":"Kernsion","avatar":"https://static.tigerbbs.com/1ffac41f60c526771b9ca04ae229744f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3574200728285353","authorIdStr":"3574200728285353"},"content":"Done, reply please","text":"Done, reply please","html":"Done, reply please"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":195730302,"gmtCreate":1621313819906,"gmtModify":1704355640253,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"This means Tesla may continue to drop in prices.. oh no! Please like and comment, thanks","listText":"This means Tesla may continue to drop in prices.. oh no! Please like and comment, thanks","text":"This means Tesla may continue to drop in prices.. oh no! Please like and comment, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/195730302","repostId":"1187982931","repostType":4,"isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3584402460044643","authorId":"3584402460044643","name":"Tradegoods","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3584402460044643","authorIdStr":"3584402460044643"},"content":"Any tips on how to grow your money bigger?","text":"Any tips on how to grow your money bigger?","html":"Any tips on how to grow your money bigger?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832505823,"gmtCreate":1629647737662,"gmtModify":1676530085762,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/832505823","repostId":"1115632642","repostType":4,"repost":{"id":"1115632642","kind":"news","pubTimestamp":1629471872,"share":"https://ttm.financial/m/news/1115632642?lang=&edition=full_marsco","pubTime":"2021-08-20 23:04","market":"us","language":"en","title":"Contrarian Investors Should Love Emerging Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1115632642","media":"Bloomberg","summary":"Stocks in developing countries are lagging behind those in the U.S. They could be poised to outperfo","content":"<blockquote>\n <b>Stocks in developing countries are&nbsp;lagging behind those in the U.S. They could be poised to outperform in the coming years.</b>\n</blockquote>\n<p>Emerging markets get no respect. Theyaccountfor about two-fifths of global gross domestic product and a quarter of global stocks by market value, and yet they’re a fraction of &nbsp;most U.S. investors’ stock portfolios. If there’s ever a time to give emerging markets another look, this is it.</p>\n<p>That’s because emerging-market stocks are lagging behind those in the U.S. by the biggest margin in two decades. The last time they were beaten this badly was when a wave of crises in developing countries slammed their stock markets during the late 1990s while dot-com mania lifted U.S. stocks to historic heights.</p>\n<p><img src=\"https://static.tigerbbs.com/dd22e89c12797121db43fe00543e1eb7\" tg-width=\"669\" tg-height=\"402\" width=\"100%\" height=\"auto\"></p>\n<p>This time it’s about profits. U.S. companies have increased earnings at arecord ratein recent years while earnings growth in emerging markets has barely budged. Since 2010, earnings per share for the S&amp;P 500 Index has grown 9.5% a year, compared with just 2.7% for the MSCI Emerging Markets Index. It wasn’t always this way. From 1995 to 2009, the first year for which numbers are available for emerging markets, earnings grew at roughly the same pace in developing countries as in the U.S., about 4% a year.</p>\n<p>Given the sharp divergence in earnings growth since 2010, the U.S. may seem like the better place to invest, even when all available earnings numbers are considered. Earnings growth, after all, is a key component of stock returns, and the U.S. is producing more of it. Assuming analysts’ estimates for this year and next are reliable, the S&amp;P 500 will have grown earnings 7.3% a year from 1995 to 2022, compared with just 4.4% a year for emerging markets. If U.S. companies were to maintain that lead, all else equal, expected returns would be 2.9 percentage points a year higher in the U.S. than in emerging markets.</p>\n<p><img src=\"https://static.tigerbbs.com/30aba59eba1452ca5a877020ce216bec\" tg-width=\"633\" tg-height=\"418\" width=\"100%\" height=\"auto\">But earnings growth isn’t the only driver of stock returns. Dividends and valuations play a role, too. When all three variables are considered, emerging markets appear to be the better bet. Analysts expect a dividend yield of 3% from emerging markets, compared with 1.5% for the S&amp;P 500. When combined with earnings growth, the advantage for U.S. stocks shrinks to 1.4 percentage points a year.</p>\n<p>Stocks are also much cheaper in emerging markets. They trade at 12 times next year’s earnings, whereas the comparable price-to-earnings ratio for the S&amp;P 500 is 20 times. That valuation gap tips the scale in favor of emerging markets. One way to compare price to expected payoff is to take a ratio of P/E to the sum of expected earnings growth and dividend yield (the lower the ratio the better). Based on the previous numbers, that ratio is 1.7 for emerging markets and 2.3 for the S&amp;P 500.</p>\n<p>And that may be the best case for U.S. stocks because it assumes U.S. companies will continue generating higher earnings growth and commanding much higher valuations than those in emerging markets, both questionable assumptions. It’s not obvious why earnings growth should be higher in the U.S. Investment in research and development, for instance, has beenshown to boost growth, and emerging-market companies spend as much on R&amp;D as a percentage of sales as companies in the U.S. In fact, they may soon spend more, as R&amp;D investment in emerging markets has grown at more than three times the U.S. rate since 1995.</p>\n<p>If anything, it’s more likely that earnings growth in emerging markets will outpace the U.S. in the years ahead. Developing economies are growing faster than the U.S., a tailwind for their companies, particularly as they grab market share in their countries from American companies. Also, given that recent earnings growth has been unusually high in the U.S. and strangely low in emerging markets, the roles may reverse for a while, bringing earnings growth between them closer to parity.</p>\n<p>The valuation gap between emerging markets and the U.S. could also narrow. The U.S. is rightly perceived as the safer place to invest, so it makes sense that investors are willing to pay more for U.S. companies. But how much more? The difference in P/E ratio based on forward earnings has averaged 4.7 times since 2005, the longest period for which numbers are available, and has rarely been as wide as it is today. If the gap were to close, it would be another boost for emerging markets relative to the U.S.</p>\n<p><img src=\"https://static.tigerbbs.com/8b9fb774ffbe544f200ac13222ee3b5e\" tg-width=\"649\" tg-height=\"371\" width=\"100%\" height=\"auto\">All of that may explain why theconsensus among big money managersis that emerging markets will deliver higher returns than the U.S. in coming years. Value stocks in emerging markets may perform even better. With a price tag of just 9 times forward earnings, they could credibly be called the most despised stocks on the planet.</p>\n<p>Contrarian investors have taken note. Boston based money manager GMOestimatesthat emerging-market value stocks will return 3.2% a year after inflation over the next seven years, compared with a negative 8.2% a year for U.S. stocks. Rob Arnott, founder of index provider Research Affiliates, hassaidthat half of his liquid investments are invested in value stocks from developing countries.</p>\n<p>It’s worth noting that the last time emerging market stocks performed this badly relative to the U.S., they went on to beat the S&amp;P 500 by 14 percentage points a year from 2000 to 2007, and value stocks won by 15 percentage points a year. They did it by paying a higher dividend yield than U.S. stocks, generating nearly four times the earnings growth as U.S. companies and expanding their valuations while that of the S&amp;P 500 was cut by more than a third.</p>\n<p>I’m not suggesting investors replace their U.S. stocks with ones in emerging markets. But developing countries now account for about 12% of the MSCI All Country World Index, a widely followed gauge of the global stock market. Stock portfolios that allocate less than that to emerging markets should ask why — and it won’t be easy to answer.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Contrarian Investors Should Love Emerging Markets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nContrarian Investors Should Love Emerging Markets\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/opinion/articles/2021-08-19/personal-finance-contrarian-investors-should-love-emerging-markets?srnd=opinion><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks in developing countries are lagging behind those in the U.S. They could be poised to outperform in the coming years.\n\nEmerging markets get no respect. Theyaccountfor about two-fifths of global ...</p>\n\n<a href=\"https://www.bloomberg.com/opinion/articles/2021-08-19/personal-finance-contrarian-investors-should-love-emerging-markets?srnd=opinion\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.bloomberg.com/opinion/articles/2021-08-19/personal-finance-contrarian-investors-should-love-emerging-markets?srnd=opinion","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115632642","content_text":"Stocks in developing countries are lagging behind those in the U.S. They could be poised to outperform in the coming years.\n\nEmerging markets get no respect. Theyaccountfor about two-fifths of global gross domestic product and a quarter of global stocks by market value, and yet they’re a fraction of  most U.S. investors’ stock portfolios. If there’s ever a time to give emerging markets another look, this is it.\nThat’s because emerging-market stocks are lagging behind those in the U.S. by the biggest margin in two decades. The last time they were beaten this badly was when a wave of crises in developing countries slammed their stock markets during the late 1990s while dot-com mania lifted U.S. stocks to historic heights.\n\nThis time it’s about profits. U.S. companies have increased earnings at arecord ratein recent years while earnings growth in emerging markets has barely budged. Since 2010, earnings per share for the S&P 500 Index has grown 9.5% a year, compared with just 2.7% for the MSCI Emerging Markets Index. It wasn’t always this way. From 1995 to 2009, the first year for which numbers are available for emerging markets, earnings grew at roughly the same pace in developing countries as in the U.S., about 4% a year.\nGiven the sharp divergence in earnings growth since 2010, the U.S. may seem like the better place to invest, even when all available earnings numbers are considered. Earnings growth, after all, is a key component of stock returns, and the U.S. is producing more of it. Assuming analysts’ estimates for this year and next are reliable, the S&P 500 will have grown earnings 7.3% a year from 1995 to 2022, compared with just 4.4% a year for emerging markets. If U.S. companies were to maintain that lead, all else equal, expected returns would be 2.9 percentage points a year higher in the U.S. than in emerging markets.\nBut earnings growth isn’t the only driver of stock returns. Dividends and valuations play a role, too. When all three variables are considered, emerging markets appear to be the better bet. Analysts expect a dividend yield of 3% from emerging markets, compared with 1.5% for the S&P 500. When combined with earnings growth, the advantage for U.S. stocks shrinks to 1.4 percentage points a year.\nStocks are also much cheaper in emerging markets. They trade at 12 times next year’s earnings, whereas the comparable price-to-earnings ratio for the S&P 500 is 20 times. That valuation gap tips the scale in favor of emerging markets. One way to compare price to expected payoff is to take a ratio of P/E to the sum of expected earnings growth and dividend yield (the lower the ratio the better). Based on the previous numbers, that ratio is 1.7 for emerging markets and 2.3 for the S&P 500.\nAnd that may be the best case for U.S. stocks because it assumes U.S. companies will continue generating higher earnings growth and commanding much higher valuations than those in emerging markets, both questionable assumptions. It’s not obvious why earnings growth should be higher in the U.S. Investment in research and development, for instance, has beenshown to boost growth, and emerging-market companies spend as much on R&D as a percentage of sales as companies in the U.S. In fact, they may soon spend more, as R&D investment in emerging markets has grown at more than three times the U.S. rate since 1995.\nIf anything, it’s more likely that earnings growth in emerging markets will outpace the U.S. in the years ahead. Developing economies are growing faster than the U.S., a tailwind for their companies, particularly as they grab market share in their countries from American companies. Also, given that recent earnings growth has been unusually high in the U.S. and strangely low in emerging markets, the roles may reverse for a while, bringing earnings growth between them closer to parity.\nThe valuation gap between emerging markets and the U.S. could also narrow. The U.S. is rightly perceived as the safer place to invest, so it makes sense that investors are willing to pay more for U.S. companies. But how much more? The difference in P/E ratio based on forward earnings has averaged 4.7 times since 2005, the longest period for which numbers are available, and has rarely been as wide as it is today. If the gap were to close, it would be another boost for emerging markets relative to the U.S.\nAll of that may explain why theconsensus among big money managersis that emerging markets will deliver higher returns than the U.S. in coming years. Value stocks in emerging markets may perform even better. With a price tag of just 9 times forward earnings, they could credibly be called the most despised stocks on the planet.\nContrarian investors have taken note. Boston based money manager GMOestimatesthat emerging-market value stocks will return 3.2% a year after inflation over the next seven years, compared with a negative 8.2% a year for U.S. stocks. Rob Arnott, founder of index provider Research Affiliates, hassaidthat half of his liquid investments are invested in value stocks from developing countries.\nIt’s worth noting that the last time emerging market stocks performed this badly relative to the U.S., they went on to beat the S&P 500 by 14 percentage points a year from 2000 to 2007, and value stocks won by 15 percentage points a year. They did it by paying a higher dividend yield than U.S. stocks, generating nearly four times the earnings growth as U.S. companies and expanding their valuations while that of the S&P 500 was cut by more than a third.\nI’m not suggesting investors replace their U.S. stocks with ones in emerging markets. But developing countries now account for about 12% of the MSCI All Country World Index, a widely followed gauge of the global stock market. Stock portfolios that allocate less than that to emerging markets should ask why — and it won’t be easy to answer.","news_type":1},"isVote":1,"tweetType":1,"viewCount":518,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138984488,"gmtCreate":1621905264344,"gmtModify":1704364150818,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like and comment please, ty","listText":"Like and comment please, ty","text":"Like and comment please, ty","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/138984488","repostId":"2138159407","repostType":4,"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133458893,"gmtCreate":1621788317212,"gmtModify":1704362413812,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Comment and like please&nbsp;","listText":"Comment and like please&nbsp;","text":"Comment and like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/133458893","repostId":"2137906121","repostType":4,"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151018919,"gmtCreate":1625057165431,"gmtModify":1703734997909,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like please, thank u","listText":"Like please, thank u","text":"Like please, thank u","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/151018919","repostId":"1195094821","repostType":4,"isVote":1,"tweetType":1,"viewCount":213,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886918874,"gmtCreate":1631543155898,"gmtModify":1676530571570,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886918874","repostId":"1170383544","repostType":4,"repost":{"id":"1170383544","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631542185,"share":"https://ttm.financial/m/news/1170383544?lang=&edition=full_marsco","pubTime":"2021-09-13 22:09","market":"us","language":"en","title":"Hot chinese concept stocks dipped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1170383544","media":"Tiger Newspress","summary":"Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RL","content":"<p>Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RLX Technology&nbsp;and&nbsp;Tencent music&nbsp;between 1% and 9%.</p>\n<p><img src=\"https://static.tigerbbs.com/634dbf9be8ba7edcb7ca8b9b2e7f1e6a\" tg-width=\"362\" tg-height=\"715\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hot chinese concept stocks dipped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHot chinese concept stocks dipped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-13 22:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RLX Technology&nbsp;and&nbsp;Tencent music&nbsp;between 1% and 9%.</p>\n<p><img src=\"https://static.tigerbbs.com/634dbf9be8ba7edcb7ca8b9b2e7f1e6a\" tg-width=\"362\" tg-height=\"715\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TME":"腾讯音乐","RLX":"雾芯科技","BABA":"阿里巴巴","DIDI":"滴滴(已退市)","BIDU":"百度","PDD":"拼多多"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170383544","content_text":"Hot chinese concept stocks dipped in morning trading.Alibaba,Pinduoduo,JD.COM,Baidu,DIDI,Bilibili,RLX Technology and Tencent music between 1% and 9%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166326614,"gmtCreate":1623992846038,"gmtModify":1703825984414,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Hope Ali returns to its high! Like and comment please","listText":"Hope Ali returns to its high! Like and comment please","text":"Hope Ali returns to its high! Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/166326614","repostId":"1175693382","repostType":4,"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3584590460416016","authorId":"3584590460416016","name":"hzrz","avatar":"https://static.tigerbbs.com/e7ba0fce733a8456f5f07f30c277f9b9","crmLevel":1,"crmLevelSwitch":0,"idStr":"3584590460416016","authorIdStr":"3584590460416016"},"content":"Comment back thx","text":"Comment back thx","html":"Comment back thx"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115897803,"gmtCreate":1622967794702,"gmtModify":1704193924821,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like and comment please, thank you","listText":"Like and comment please, thank you","text":"Like and comment please, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/115897803","repostId":"1106312903","repostType":4,"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":131303090,"gmtCreate":1621824660410,"gmtModify":1704362849869,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/131303090","repostId":"2137827351","repostType":4,"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":104183046,"gmtCreate":1620363316585,"gmtModify":1704342608685,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Undervalued but still px too high for me, haha. Like and comment please, ty","listText":"Undervalued but still px too high for me, haha. Like and comment please, ty","text":"Undervalued but still px too high for me, haha. Like and comment please, ty","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/104183046","repostId":"1157328258","repostType":4,"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3555321706323687","authorId":"3555321706323687","name":"KingMeng","avatar":"https://static.tigerbbs.com/2a4230fd8d7c8381fff3acc8774ac46e","crmLevel":1,"crmLevelSwitch":0,"idStr":"3555321706323687","authorIdStr":"3555321706323687"},"content":"done. do like and reply back. thanks!","text":"done. do like and reply back. thanks!","html":"done. do like and reply back. thanks!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836699865,"gmtCreate":1629473325657,"gmtModify":1676530054166,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like please?&nbsp;","listText":"Like please?&nbsp;","text":"Like please?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/836699865","repostId":"2160710721","repostType":4,"repost":{"id":"2160710721","kind":"news","pubTimestamp":1629473265,"share":"https://ttm.financial/m/news/2160710721?lang=&edition=full_marsco","pubTime":"2021-08-20 23:27","market":"us","language":"en","title":"Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?","url":"https://stock-news.laohu8.com/highlight/detail?id=2160710721","media":"Zacks","summary":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. ","content":"<p><b>Moderna</b>’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a <a href=\"https://laohu8.com/S/WASH\">Washington</a> <a href=\"https://laohu8.com/S/POST\">Post</a> article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>/<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>’s mRNA-based vaccine, BNT162b.</p>\n<p>Per the same <a href=\"https://laohu8.com/S/WRE\">Washington</a> Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.</p>\n<p>We note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.</p>\n<p>Meanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.</p>\n<p>Shares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/01ae6084260e85bc39bcd6d72d8d9ae0\" tg-width=\"620\" tg-height=\"406\" referrerpolicy=\"no-referrer\"></p>\n<p>Image Source: Zacks Investment Research</p>\n<p>We note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with <b>J&amp;J</b>’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.</p>\n<p>Meanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination.&nbsp;The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).</p>\n<h3><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> Price</h3>\n<p><img src=\"https://static.tigerbbs.com/33512fafdd460236be3b7bc6e113462a\" tg-width=\"545\" tg-height=\"257\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> price | Moderna, Inc. Quote</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Moderna (MRNA) COVID-19 Jab Heart Risk More Than Pfizer's?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/moderna-mrna-covid-19-jab-131601604.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2160710721","content_text":"Moderna’s MRNA mRNA-based COVID-19 vaccine, mRNA-1273 is being investigated by the FDA and the U.S. Centers for Disease Control and Prevention (CDC) for higher risk of myocarditis, a rare condition of heart inflammation, in younger adults per a Washington Post article. The article implies that the risk of myocarditis following inoculation with mRNA-1273 can be more than previously thought and is also higher than Pfizer/BioNTech SE’s mRNA-based vaccine, BNT162b.\nPer the same Washington Post article, the claims of higher risk of myocarditis, especially for males below the age of 30 or so, following Moderna’s jab are majorly based on data from Canada. The same data suggests that vaccination with mRNA-1273 may increase the risk of incidence of myocarditis by 2.5-fold compared to BNT162b. U.S. health officials are currently reviewing the data as well as data generated in the United States for a possible link to higher risk of heart inflammation. The report stated that the officials believe it is too early to conclude and issue any kind of new or revised warning or recommendation for mRNA-1273.\nWe note that Pfizer’s BNT162b is already leading the vaccination race with $11.3 billion sales in the first half of 2021 compared to nearly $6 billion of sales from mRNA-1273. Moreover, the anticipated sales for 2021 for BNT162b and mRNA-1273 stands at $33.5 billion and approximately $19.2 billion, respectively.\nMeanwhile, U.S. health officials have decided to start providing booster doses to the country’s citizens beginning in the first week of fall that will start on Sep 20. Amid rising support for booster doses for better protection against the Delta variant, the potential link to higher risk of heart inflammation may hurt demand for Moderna’s mRNA-1273, pushing it further back in the competition. Moreover, a few new COVID-19 vaccines may enter the U.S. markets this year, which will result in increased competition.\nShares of Moderna fell 5.8% on Aug 19, following the reports on probe for higher risk of heart inflammation. The company’s shares have surged 259.4% so far this year against the industry’s decrease of 0.3%.\n\nImage Source: Zacks Investment Research\nWe note that the CDC concluded earlier in June that there is a “likely association” between mRNA-based COVID-19 vaccines and increased cases of heart inflammation, including myocarditis and pericarditis, in adolescents and younger adults. Heart inflammation was reported after the first dose of mRNA-1273 and BNT162b in a small proportion of individuals,which increased further following the second dose. However, similar inflammation cases were not reported following vaccination with J&J’s JNJ adenovirus-based COVID-19 vaccine. Following the investigation, the labels of both mRNA-based vaccines were updated to include a warning label for increased risk of myocarditis.\nMeanwhile, the United States is not the only country to probe various risks with possible links to mRNA-based COVID-19 vaccines. Earlier this month, the European Medicines Agency initiated an investigation to study three new conditions found in a small proportion of individuals receiving mRNA-based vaccination. The individuals immunized with an mRNA-based vaccine reported that they developed either erythema multiforme (allergic skin reaction), glomerulonephritis (kidney inflammation) and/or nephrotic syndrome (renal disorder).\nModerna, Inc. Price\n\nModerna, Inc. price | Moderna, Inc. Quote","news_type":1},"isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895058891,"gmtCreate":1628696261213,"gmtModify":1676529825719,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Why wld they return the money... hmm pls like","listText":"Why wld they return the money... hmm pls like","text":"Why wld they return the money... hmm pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/895058891","repostId":"2158804152","repostType":4,"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801313809,"gmtCreate":1627482457301,"gmtModify":1703490880077,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Like please? Thanks","listText":"Like please? Thanks","text":"Like please? Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/801313809","repostId":"2154360923","repostType":4,"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126038852,"gmtCreate":1624536791676,"gmtModify":1703839659209,"author":{"id":"3582110607927501","authorId":"3582110607927501","name":"Syrope","avatar":"https://static.tigerbbs.com/7ddaf202594282f1436af195f5cd39e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582110607927501","authorIdStr":"3582110607927501"},"themes":[],"htmlText":"Tesla keep rising pls","listText":"Tesla keep rising pls","text":"Tesla keep rising pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/126038852","repostId":"1195543409","repostType":4,"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}